<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Bioinform Biol Insights</journal-id><journal-id journal-id-type="iso-abbrev">Bioinform Biol Insights</journal-id><journal-id journal-id-type="pmc-domain-id">898</journal-id><journal-id journal-id-type="pmc-domain">bbi</journal-id><journal-id journal-id-type="publisher-id">BBI</journal-id><journal-title-group><journal-title>Bioinformatics and Biology Insights</journal-title></journal-title-group><issn pub-type="epub">1177-9322</issn><publisher><publisher-name>SAGE Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10350588</article-id><article-id pub-id-type="pmcid-ver">PMC10350588.2</article-id><article-id pub-id-type="pmcaid">10350588</article-id><article-id pub-id-type="pmcaiid">10350759</article-id><article-id pub-id-type="pmid">37461741</article-id><article-id pub-id-type="doi">10.1177/11779322231186481</article-id><article-id pub-id-type="publisher-id">10.1177_11779322231186481</article-id><article-version article-version-type="pmc-version">2</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research Article</subject></subj-group></article-categories><title-group><article-title>Molecular Biomarker Identification Using a Network-Based Bioinformatics Approach That Links COVID-19 With Smoking</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Rahman</surname><given-names initials="MA">Md Anisur</given-names></name><xref rid="aff1-11779322231186481" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Amin</surname><given-names initials="MA">Md Al</given-names></name><xref rid="aff2-11779322231186481" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yeasmin</surname><given-names initials="MN">Most Nilufa</given-names></name><xref rid="aff3-11779322231186481" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Islam</surname><given-names initials="MZ">Md Zahidul</given-names></name><xref rid="aff3-11779322231186481" ref-type="aff">3</xref><xref rid="corresp1-11779322231186481" ref-type="corresp"/></contrib></contrib-group><aff id="aff1-11779322231186481"><label>1</label>Department of Pharmacy, Islamic University, Kushtia, Bangladesh</aff><aff id="aff2-11779322231186481"><label>2</label>Department of Computer Science &amp; Engineering, Prime University, Dhaka, Bangladesh</aff><aff id="aff3-11779322231186481"><label>3</label>Department of Information &amp; Communication Technology, Islamic University, Kushtia, Bangladesh</aff><author-notes><corresp id="corresp1-11779322231186481">Md Zahidul Islam, Department of Information &amp; Communication Technology, Islamic University, Kushtia 7003, Bangladesh. Email: <email>zahidimage@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>14</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>17</volume><issue-id pub-id-type="pmc-issue-id">426507</issue-id><elocation-id>11779322231186481</elocation-id><history><date date-type="received"><day>18</day><month>12</month><year>2022</year></date><date date-type="accepted"><day>21</day><month>6</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>14</day><month>07</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>17</day><month>07</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-09-19 14:41:25.413"><day>19</day><month>09</month><year>2023</year></date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">10350588</article-id><article-id pub-id-type="doi">10.1177/11779322231186481</article-id><article-version>1</article-version><pub-date><day>14</day><month>07</month><year>2023</year></pub-date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">10350759</article-id><article-id pub-id-type="doi">10.1177/11779322231186481</article-id><article-version>2</article-version><pub-date><day>14</day><month>07</month><year>2023</year></pub-date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder content-type="sage">SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10.1177_11779322231186481.pdf"/><abstract><p>The COVID-19 coronavirus, which primarily affects the lungs, is the source of the disease known as SARS-CoV-2. According to &#8220;Smoking and COVID-19: a scoping review,&#8221; about 32% of smokers had a severe case of COVID-19 pneumonia at their admission time and 15% of non-smokers had this case of COVID-19 pneumonia. We were able to determine which genes were expressed differently in each group by comparing the expression of gene transcriptomic datasets of COVID-19 patients, smokers, and healthy controls. In all, 37 dysregulated genes are common in COVID-19 patients and smokers, according to our analysis. We have applied all important methods namely protein-protein interaction, hub-protein interaction, drug-protein interaction, tf-gene interaction, and gene-MiRNA interaction of bioinformatics to analyze to understand deeply the connection between both smoking and COVID-19 severity. We have also analyzed Pathways and Gene Ontology where 5 significant signaling pathways were validated with previous literature. Also, we verified 7 hub-proteins, and finally, we validated a total of 7 drugs with the previous study.</p></abstract><kwd-group><kwd>Smoking</kwd><kwd>COVID-19</kwd><kwd>bio-informatics</kwd><kwd>GSEA</kwd><kwd>gene ontology</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January-December 2023</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="section1-11779322231186481"><title>Introduction</title><p>The COVID-19 coronavirus, as known as the SARS-CoV-2 virus, is an extremely contagious disease that mostly affects the lungs<sup><xref rid="bibr1-11779322231186481" ref-type="bibr">1</xref>,<xref rid="bibr2-11779322231186481" ref-type="bibr">2</xref></sup> since 2019 in the month of December. It has been resulted that more than 540.92 million people are newly affected while 6.3 million people losing their life in all over the world.<sup>
<xref rid="bibr3-11779322231186481" ref-type="bibr">3</xref>
</sup> According to a World Health Organization (WHO) investigation, it is estimated that it caused 14.9 million deaths in direct and indirect ways between 2020 and 2021.<sup>
<xref rid="bibr4-11779322231186481" ref-type="bibr">4</xref>
</sup> The virus has spread to nearly every country and has caused widespread social upheaval.<sup>
<xref rid="bibr5-11779322231186481" ref-type="bibr">5</xref>
</sup> As per that, a history of smoking raises the risk of developing COVID-19 with a severe illness and smokers are more likely to experience it.<sup><xref rid="bibr6-11779322231186481" ref-type="bibr">6</xref>,<xref rid="bibr7-11779322231186481" ref-type="bibr">7</xref></sup> Furthermore, Chinese COVID-19 patients indicated that 32% of smokers (including current and former smokers) had a severe pattern of COVID-19 lung disease when they were admitted, compared to 15% of those who had never smoked.<sup>
<xref rid="bibr8-11779322231186481" ref-type="bibr">8</xref>
</sup> Another research represented that tobacco smoking affects and damages the epithelial cell of the lungs.<sup>
<xref rid="bibr9-11779322231186481" ref-type="bibr">9</xref>
</sup> Because of that, it facilitates the virus entry into the lungs&#8217; epithelial cells,<sup>
<xref rid="bibr10-11779322231186481" ref-type="bibr">10</xref>
</sup> causing more severe symptoms and increasing the risk of death.<sup><xref rid="bibr8-11779322231186481" ref-type="bibr">8</xref>,<xref rid="bibr11-11779322231186481" ref-type="bibr">11</xref></sup> Moreover, the ACE2 (angiotensin-converting enzyme-2) receptor is also highly expressed in this type of patients and smoking helps to express the ACE2 receptor.<sup>
<xref rid="bibr12-11779322231186481" ref-type="bibr">12</xref>
</sup> According to a prior study, the main host cell receptor of COVID-19 is ACE2 receptor which is essential for the virus to enter cells in order to cause infection.<sup>
<xref rid="bibr13-11779322231186481" ref-type="bibr">13</xref>
</sup> In addition, the outcomes of cigarette smoke can be worsen in COVID-19 patients by up-regulating the angiotensin-converting enzyme-2 (ACE-2) receptor that SARS-CoV-2 uses to enter the host cell and trigger a &#8220;cytokine storm.&#8221;<sup><xref rid="bibr14-11779322231186481" ref-type="bibr">14</xref>,<xref rid="bibr15-11779322231186481" ref-type="bibr">15</xref></sup> Patients with COVID-19 had fewer natural killer (NK) cells, which affect adaptive and innate immunity and significantly increase CD8+ T cell expression.<sup>
<xref rid="bibr16-11779322231186481" ref-type="bibr">16</xref>
</sup> Similarly, smokers had a larger percentage of CD8+&#8201;T cells and fewer circulating NK cells than nonsmokers.<sup><xref rid="bibr14-11779322231186481" ref-type="bibr">14</xref>,<xref rid="bibr17-11779322231186481" ref-type="bibr">17</xref></sup> In another study, smoking affects the platelet directly and accelerates blood coagulation.<sup><xref rid="bibr18-11779322231186481" ref-type="bibr">18</xref>,<xref rid="bibr19-11779322231186481" ref-type="bibr">19</xref></sup> Patients with COVID-19 have also been reported to have coagulation abnormalities, primarily thrombotic complications, and the occurrence of venous and arterial thrombotic abnormalities in COVID-19 patients who are admitted to the intensive care unit (ICU) may climb 31%.<sup>
<xref rid="bibr20-11779322231186481" ref-type="bibr">20</xref>
</sup> Smoking on a regular basis has been shown to facilitate the progression of COVID-19 and rise the threat of various complications in COVID-19 patients. Consequently, we have attempted to identify shared common gene between COVID-19 and smoking. Moreover, there is still a requirement for the relationship between COVID-19 and smoking in bioinformatics analysis that is too important for future research. Finally, our study helps us to understand an important advice about the severity of COVID-19 patients with a smoking history and a resource for pharmaceutical companies wishing to create effective drugs that will reduce the number of difficulties for COVID-19 patients who were ex-smokers. We created 9 (Differential Expressed Common Genes [DEGs], Gene Ontology (GO), Pathways, Hub-Protein, Transcription Factor, Gene Interactions, Gene miRNA Interaction, Protein-Drug Interaction, and Protein-Protein Interaction [PPI]) bioinformatics systems in response to these findings to analyze data on gene expression from COVID-19 patients and people who smoke to better understand their association with each other. To understand that deeply, we have analyzed above 9 biological systems between COVID-19 and smoking in this study. We have depicted our methodology of the hypothesis as shown in <xref rid="fig1-11779322231186481" ref-type="fig">Figure 1</xref>.</p><fig position="float" id="fig1-11779322231186481" orientation="portrait"><label>Figure 1.</label><caption><p>Graphical representation of the underlying procedure of this research.</p><p>miRNA indicates microRNA; BMC indicates peripheral blood mononuclear cell; GSE indicates gene set enrichment.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-fig1.jpg"/></fig></sec><sec sec-type="materials|methods" id="section2-11779322231186481"><title>Materials and Methods</title><sec id="section3-11779322231186481"><title>Dataset employed in this study</title><p>The National Center for Biotechnology Information (NCBI)<sup>
<xref rid="bibr21-11779322231186481" ref-type="bibr">21</xref>
</sup> and the Gene Expression Omnibus (GEO) are the sources of our data sets.<sup>
<xref rid="bibr22-11779322231186481" ref-type="bibr">22</xref>
</sup> We chose the data set based on a number of criteria, including sample size (minimum 8), and only one condition control versus case (case vs treatment condition was avoided), RNAseq data, and datasets without human creatures. The data set chosen was count data, and differential expression analysis was performed correctly. Unfavorable formatting and datasets that were not relevant to our research goals were excluded. At least 2 datasets, particularly relevant to Covid-19 and smoking, were chosen based on the most appropriate criteria. The datasets with the association numbers <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE152418">GSE152418</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE76326">GSE76326</ext-link> were analyzed from RNA-seq human gene expression datasets. Both have control and case (disease-affected) samples, which are both ideal for our study. We assayed the datasets which bear the association numbers <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE152418">GSE152418</ext-link><sup>
<xref rid="bibr23-11779322231186481" ref-type="bibr">23</xref>
</sup> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE76326">GSE76326</ext-link><sup>
<xref rid="bibr24-11779322231186481" ref-type="bibr">24</xref>
</sup> from RNAseq human gene expression datasets. Both have control and case (disease-affected) samples, individually perfectly suited for this study. The COVID-19 dataset (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE152418">GSE152418</ext-link>) contained 6 COVID-19 patients and 3 control or healthy people using Illumina NOVAseq 6000 (<italic toggle="yes">Homo sapiens</italic>). The Smoking dataset (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE76326">GSE76326</ext-link>) contained an assessment of the immunity of 6 Smoking patients and 3 control or healthy people using Illumina HiSeq 2000 (<italic toggle="yes">Homo sapiens</italic>) as shown in <xref rid="table1-11779322231186481" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="table1-11779322231186481" orientation="portrait"><label>Table 1.</label><caption><p>The summary of the transcriptomic data and analysis.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-table1.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Disease name</th><th align="left" rowspan="1" colspan="1">GEO platform</th><th align="left" rowspan="1" colspan="1">Tissue/cells</th><th align="left" rowspan="1" colspan="1">GEO accession</th><th align="left" rowspan="1" colspan="1">RAW genes</th><th align="left" rowspan="1" colspan="1">Case samples</th><th align="left" rowspan="1" colspan="1">Control samples</th><th align="left" rowspan="1" colspan="1">Significant</th><th align="left" rowspan="1" colspan="1">Up reg. genes</th><th align="left" rowspan="1" colspan="1">Down reg. genes</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">COVID-19</td><td rowspan="1" colspan="1">Illumina NextSeq 6000(Homo sapiens)</td><td rowspan="1" colspan="1">PBMC</td><td rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE152418">GSE152418</ext-link></td><td rowspan="1" colspan="1">21135</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">12379</td><td rowspan="1" colspan="1">1942</td><td rowspan="1" colspan="1">327</td></tr><tr><td rowspan="1" colspan="1">Smoking</td><td rowspan="1" colspan="1">Illumina HiSeq 2000(Homo sapiens)</td><td rowspan="1" colspan="1">Airway Basal Cells</td><td rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE76326">GSE76326</ext-link></td><td rowspan="1" colspan="1">21178</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">466</td><td rowspan="1" colspan="1">392</td><td rowspan="1" colspan="1">60</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-11779322231186481"><p>Abbreviation: GEO, gene expression omnibus; MHC, major histocompatibility complex; ER, estrogen receptor; RAW genes, primary genes.</p></fn><fn id="table-fn2-11779322231186481"><p>It includes the dataset accession number, sample source, total raw genes, sample number, significant genes.</p></fn></table-wrap-foot></table-wrap></sec><sec id="section4-11779322231186481"><title>Preparation and recognition of genes with differential expression</title><p>Again from GREIN (it is the most common and unique source of GEO RNA-seq data which is a combination of a huge number of back and front end data and user-friendly interface.<sup>
<xref rid="bibr25-11779322231186481" ref-type="bibr">25</xref>
</sup> Gene Expression Omnibus, we acquired gene regulation RNA-sequence datasets. Using the Rstudio DESeq2, genes with differential expression (DEGs) of COVID-19 as well as smoking-related RNA-Seq count data were found.<sup>
<xref rid="bibr26-11779322231186481" ref-type="bibr">26</xref>
</sup> In order to standardize the results, the geometric mean of each gene was calculated across all samples in DESeq2. Then, DESeq2 automatically filtered out low-expression and outlying genes using Cook&#8217;s distance. We have filtered the significant DEGs based on 2 conditions such as adjusted <italic toggle="yes">P</italic>-value&#8201;&#10877;&#8201;.05 and log2F C&#8201;&#10878;&#8201;1. We found common DEGs between COVID-19 and smoking by creating a Venn diagram as shown in <xref rid="fig2-11779322231186481" ref-type="fig">Figure 2</xref>.</p><fig position="float" id="fig2-11779322231186481" orientation="portrait"><label>Figure 2.</label><caption><p>The gene-expression analysis summary was shown in the figure. (A) Venn diagram showing the shared biomarker genes respectively COVID-19 as well as smoking. (B) Bubble plot of common biomarker genes and their corresponding Log2 fold change and adjusted AP-value.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-fig2.jpg"/></fig></sec><sec id="section5-11779322231186481"><title>Diseasome network</title><p>Diseasome is a representation of disease maps, where the diseases are the nodes and the different molecular connections between the disease-associated cellular components (CCs) are the links. We use InteractiVenn as a bioinformatics computational tool of Diseasome Network for detecting common gene between COVID-19 and smoking. The discovery of such connections between diseases not only aids in our understanding of the molecular relationships between various phenotypes, which are frequently addressed by various medical sub-disciplines but also aids in our understanding of why particular groups of diseases co-occur.<sup>
<xref rid="bibr27-11779322231186481" ref-type="bibr">27</xref>
</sup> The disease map offers a vibrant visual representation that helps in conceptualizing the links between genes and diseases.<sup>
<xref rid="bibr28-11779322231186481" ref-type="bibr">28</xref>
</sup> Diseasomes show local clusters of diseases whose molecular links are well recognized, and they also indicate common pathophysiology between diseases by using pleiotropic genes.<sup>
<xref rid="bibr29-11779322231186481" ref-type="bibr">29</xref>
</sup> A bipartite graph with 2 separate sets of nodes is the best way to depict the disease. The illness nodes in the first set and the disease gene nodes in the second. If a gene&#8217;s mutations are linked to a disorder, the disorder and the gene are then linked. A bipartite network is one in which, like in the diseasome, the linkages always interconnect the 2 nodes from 2 distinct groups of nodes. Data from a wide range of sources must be integrated because of the complex relationship between medications, genes, and diseases. Therefore, there is a growing need for new tools to integrate, represent, and visualize heterogeneous biomedical data in order to extract biologically significant information.<sup>
<xref rid="bibr30-11779322231186481" ref-type="bibr">30</xref>
</sup></p></sec><sec id="section6-11779322231186481"><title>Gene ontology and molecular pathway identification</title><p>In order to identify functional pathways related to specific diseases, many bioinformatic techniques frequently put a heavy emphasis on assessing the significance of a gene set&#8217;s similarity to other gene sets with observations.<sup>
<xref rid="bibr31-11779322231186481" ref-type="bibr">31</xref>
</sup> We used EnrichR gene set enrichment analysis to identify the Gene Ontology (GO) terms as well as pathways connected to the overlapped DEGs for both COVID-19 as well as smokers. The analysis emphasizes GOs as well as pathways, which will undoubtedly aid in our quest to fully understand the biological processes (BP) that involve both conditions.<sup>
<xref rid="bibr32-11779322231186481" ref-type="bibr">32</xref>
</sup> The Gene Ontology (GO) project&#8217;s primary aim is to develop a standard set of gene dictionaries for describing gene products across all known species. There are 3 categories in GO terminology: CC molecular function (MF) as well as BP.<sup>
<xref rid="bibr33-11779322231186481" ref-type="bibr">33</xref>
</sup> For our study, we only took into account the BP, though. Pathways demonstrate their importance in determining how living things react to stimuli. In the field of life sciences, pathway analysis is usually employed to assist researchers to comprehend the molecular mechanisms that underlie the elevated biological data. It might also explain how various illnesses or conditions are related to one another.<sup>
<xref rid="bibr34-11779322231186481" ref-type="bibr">34</xref>
</sup></p></sec><sec id="section7-11779322231186481"><title>Protein-protein interactions analysis and hub-protein</title><p>All BPs depend on networks of protein&#8211;protein interactions (PPIs), which show the physical contacts, respectively, 2 or more biomolecules.<sup>
<xref rid="bibr35-11779322231186481" ref-type="bibr">35</xref>
</sup> We also used the STRING database<sup>
<xref rid="bibr36-11779322231186481" ref-type="bibr">36</xref>
</sup> as well as Network Analyst<sup>
<xref rid="bibr37-11779322231186481" ref-type="bibr">37</xref>
</sup> to construct PPI networks in between proteins of DEGs, which are based on their physical interactions with one another. Proteins are represented in these networks as nodes, as well as protein interactions, are expressed as edges. Protein-protein interaction analysis with topological characteristics, such as a degree of interaction greater than 15&#8201;degrees, was used to identify proteins with strong interactions. Highly interacting proteins are known as Hub Proteins.<sup>
<xref rid="bibr38-11779322231186481" ref-type="bibr">38</xref>
</sup></p></sec><sec id="section8-11779322231186481"><title>Transcription factors analysis and miRNA interactions analysis</title><p>miRNA is the name of a group of small Biomolecules (21-23 nucleotides) that control the synthesis of proteins but don&#8217;t encode any proteins.<sup>
<xref rid="bibr39-11779322231186481" ref-type="bibr">39</xref>
</sup> MicroRNAs (miRNAs) are a type of non-coding small RNA that can regulate gene expression by combining with the 3&#8242;-untranslated region (UTR) of a target mRNA.<sup>
<xref rid="bibr40-11779322231186481" ref-type="bibr">40</xref>
</sup> Gene transcription is regulated by TFs, which are modular proteins that bind to the promoter regions of their target genes. As a result, TFs have the potential to increase both the rate of gene expression and the number of proteins made in this way.<sup>
<xref rid="bibr39-11779322231186481" ref-type="bibr">39</xref>
</sup> We investigated the interactions between DEGs and transcription factors (TFs) and DEGs and microRNAs in order to determine the controlling biomolecule (i.e. miRNAs and TFs) that control DEGs of involvement at the transcriptional and post-transcriptional level (miRNAs). With the help of the JASPAR database, the DEGs-TFs interaction was studied<sup>
<xref rid="bibr41-11779322231186481" ref-type="bibr">41</xref>
</sup> Utilizing TarBase<sup>
<xref rid="bibr42-11779322231186481" ref-type="bibr">42</xref>
</sup> and miRTarBase,<sup>
<xref rid="bibr43-11779322231186481" ref-type="bibr">43</xref>
</sup> we used miRNA-DEG interactions. Using Cytoscape&#8217;s Network<sup>
<xref rid="bibr44-11779322231186481" ref-type="bibr">44</xref>
</sup> Analyzer and Network Analyst<sup>
<xref rid="bibr37-11779322231186481" ref-type="bibr">37</xref>
</sup> the topological analysis was carried out. The TFs were filtered out of the DEGs-TFs network based on&#8201;&#10878;&#8201;20. The miRNAs were chosen depending on the&#8201;&#10878;&#8201;15 from the DEGs-miRNAs network.</p></sec><sec id="section9-11779322231186481"><title>Drug&#8211;protein interaction</title><p>Studying protein&#8211;drug interactions is essential to comprehending the structural requirements for ligand affinity.<sup><xref rid="bibr45-11779322231186481" ref-type="bibr">45</xref>,<xref rid="bibr46-11779322231186481" ref-type="bibr">46</xref></sup> The DrugBank<sup>
<xref rid="bibr47-11779322231186481" ref-type="bibr">47</xref>
</sup> dataset is also used to construct protein-drug interactions. We used this (version 1.0)<sup>
<xref rid="bibr48-11779322231186481" ref-type="bibr">48</xref>
</sup> database to find potential medications that significantly interact with genes. The DSigDB is a free online tool that provides a list of drugs and the genes they are meant to target (GSEA). There are currently 22527 gene sets, which include 17389, in this dataset, by using EnrichrR<sup>
<xref rid="bibr49-11779322231186481" ref-type="bibr">49</xref>
</sup> web server and DSigDB database, we chose the enriched drugs for the DEGs utilizing the statistical criterion, adjusted <italic toggle="yes">P</italic>-value&#8201;&#10877;&#8201;.05.</p></sec></sec><sec sec-type="results" id="section10-11779322231186481"><title>Result</title><sec id="section11-11779322231186481"><title>Evaluation of transcriptomic data for gene expression</title><p>Both databases were made using prior research that included earlier published GWAS results. To study how smoking and COVID-19 patients&#8217; genes are expressed, we collected RNA-Seq data from GREIN or NCBI. <xref rid="table1-11779322231186481" ref-type="table">Table 1</xref> shows that the COVID-19 data came from the &#8220;Illumina Next Seq 6000 (Homo sapiens)&#8221; GEO platform, while the smoking data came from the &#8220;Illumina HiSeq 2000 (Homo sapiens)&#8221; platform. The RNA-seq data for COVID-19 came from the &#8220;Peripheral Blood Mononuclear Cells&#8221; study, and the RNA-seq data for smoking came from the &#8220;Airway Basal Cells&#8221; study. For COVID-19, we&#8217;ve chosen the dataset with the GEO accession ID <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE152418">GSE152418</ext-link><sup>
<xref rid="bibr23-11779322231186481" ref-type="bibr">23</xref>
</sup> and the Smoking dataset with GEO accession ID <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-geo" xlink:href="GSE76326">GSE76326</ext-link>.<sup>
<xref rid="bibr24-11779322231186481" ref-type="bibr">24</xref>
</sup> Nine samples total&#8212;6 for the case and 3 for the control&#8212;were used in COVID-19. After differential expression analysis, also known as generated signature data, 21135 differentially expressed (DE) genes for COVID-19 were discovered. Then, 2 conditions were taken into account for the signature data, including &#8220;Log2 Fold-Change&#8221; and &#8220;Adjusted P Value.&#8221; Following the application, we identified 12379 significant genes by applying the criteria that the adjusted <italic toggle="yes">P</italic> value be less than .05 and the abs(LogFC) be higher than or equal to 1.0. Of the significant genes, 1942 are up-regulated and 327 are down-regulated.&#8221; However, there are a total of 9 samples in the Smoking dataset; 6 of them come from the case group (regular smokers), while the other after producing signature data, we identified 21178 differential expression genes. Then, using the same standards as for smoking, we found 466 significant genes. Of these, 392 are expressed positively (up-regulated), and 60 are expressed negatively (down-regulated). Then, we made a comparison between the COVID-19 upregulated genes and the upregulated smoker genes. We also compared the genes that were down-regulated in both conditions. There are 28 common genes that are upregulated and 9 common genes that are downregulated between COVID-19 and smoking as shown in <xref rid="fig3-11779322231186481" ref-type="fig">Figure 3</xref>. The most important genes that are shared up-regulated are CHPF, GP1BB, HIST1H4J, EGFL7, PLXNB3, MPL, JSRP1, KLC3, zTOX2, EVA1B, APOE, GAS2L1, NTSR1, CAVIN3, IGFALS, ADAMTS7, PITX1, RNF17, BCAR1, NPW, HGFAC, TCF19, SPDYE2B, GRIN3B, LMNTD2, SLC16A8, CYP2W1, PTGER1. Moreover, the most prominent down-regulated genes shared by COVID-19 and smoking: TIRM27, NFKBIL 1, WDR46, C4A, HLA-DQB1, HLA-C, SKIV2L, HLA-DPB1, CARS.</p><fig position="float" id="fig3-11779322231186481" orientation="portrait"><label>Figure 3.</label><caption><p>Up-regulated and Down-regulated genes between COVID-19 patients and smokers are represented separately. (A) Up-reg. (B) Down-reg.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-fig3.jpg"/></fig></sec><sec id="section12-11779322231186481"><title>Analyzing the functional associations between pathways and gene ontologies</title><p>We used KEGG, Reactome, BioCarta, WikiPathway, and Elsevier Pathway as our pathway analysis databases for this study. Then, using shared DEGs between COVID-19 and Smoking, we searched for highly expressed pathways. These pathways were then divided into functional groups for analysis as shown in <xref rid="table2-11779322231186481" ref-type="table">Table 2</xref>. In all, 345 signaling pathways were initially associated with both disease and condition. The number of pathways was then reduced by using manual curation. Consideration is given to pathways with adjusted <italic toggle="yes">P</italic>-values under .05. Using <italic toggle="yes">P</italic>-value, we get unique numbers of every gene and easily identified them. Consequently, we obtained the 238 most important signaling pathways. Finally, we organized the pathways in ascending order based on the <italic toggle="yes">P</italic>-value.</p><table-wrap position="float" id="table2-11779322231186481" orientation="portrait"><label>Table 2.</label><caption><p>Ontological analysis between COVID-19 and smoking.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-table2.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Category</th><th align="left" rowspan="1" colspan="1">GO ID</th><th align="left" rowspan="1" colspan="1">Term</th><th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>-values</th><th align="left" rowspan="1" colspan="1">Genes</th></tr></thead><tbody><tr><td rowspan="11" colspan="1">GO biological process</td><td rowspan="1" colspan="1">GO:0051764</td><td rowspan="1" colspan="1">Actin crosslink formation</td><td rowspan="1" colspan="1">.021981327</td><td rowspan="1" colspan="1">GAS2L1</td></tr><tr><td rowspan="1" colspan="1">GO:0007015</td><td rowspan="1" colspan="1">Actin filament organization</td><td rowspan="1" colspan="1">.032124121</td><td rowspan="1" colspan="1">GAS2L1; BCAR1</td></tr><tr><td rowspan="1" colspan="1">GO:0090527</td><td rowspan="1" colspan="1">Actin filament reorganization</td><td rowspan="1" colspan="1">.014706953</td><td rowspan="1" colspan="1">BCAR1</td></tr><tr><td rowspan="1" colspan="1">GO:0045010</td><td rowspan="1" colspan="1">Actin nucleation</td><td rowspan="1" colspan="1">.038158147</td><td rowspan="1" colspan="1">TRIM27</td></tr><tr><td rowspan="1" colspan="1">GO:0055090</td><td rowspan="1" colspan="1">Acylglycerol homeostasis</td><td rowspan="1" colspan="1">.045264003</td><td rowspan="1" colspan="1">APOE</td></tr><tr><td rowspan="1" colspan="1">GO:0046222</td><td rowspan="1" colspan="1">Aflatoxin metabolic process</td><td rowspan="1" colspan="1">.027402792</td><td rowspan="1" colspan="1">CYP2W1</td></tr><tr><td rowspan="1" colspan="1">GO:0046164</td><td rowspan="1" colspan="1">Alcohol catabolic process</td><td rowspan="1" colspan="1">.020167647</td><td rowspan="1" colspan="1">APOE</td></tr><tr><td rowspan="1" colspan="1">GO:0042982</td><td rowspan="1" colspan="1">Amyloid precursor protein metabolic process</td><td rowspan="1" colspan="1">.032795015</td><td rowspan="1" colspan="1">APOE</td></tr><tr><td rowspan="1" colspan="1">GO:0002484</td><td rowspan="1" colspan="1">Antigen processing and presentation of endogenous peptide antigen via MHC class I<break/>via ER pathway</td><td rowspan="1" colspan="1">.012880151</td><td rowspan="1" colspan="1">HLA-C</td></tr><tr><td rowspan="1" colspan="1">GO:0002486</td><td rowspan="1" colspan="1">Antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent</td><td rowspan="1" colspan="1">.012880151</td><td rowspan="1" colspan="1">HLA-C</td></tr><tr><td rowspan="1" colspan="1">GO:0046222</td><td rowspan="1" colspan="1">Aflatoxin metabolic process</td><td rowspan="1" colspan="1">.027402792</td><td rowspan="1" colspan="1">CYP2W1</td></tr><tr><td rowspan="10" colspan="1">GO molecular function</td><td rowspan="1" colspan="1">GO:0008376</td><td rowspan="1" colspan="1">Acetylgalactosaminyltransferase activity</td><td rowspan="1" colspan="1">.048797751</td><td rowspan="1" colspan="1">CHPF</td></tr><tr><td rowspan="1" colspan="1">GO:0005503</td><td rowspan="1" colspan="1">All-trans retinal binding</td><td rowspan="1" colspan="1">.009216659</td><td rowspan="1" colspan="1">CYP2W1</td></tr><tr><td rowspan="1" colspan="1">GO:0005503</td><td rowspan="1" colspan="1">Cell adhesion mediator activity x</td><td rowspan="1" colspan="1">.043492342</td><td rowspan="1" colspan="1">PLXNB3</td></tr><tr><td rowspan="1" colspan="1">GO:0047238</td><td rowspan="1" colspan="1">Glucuronosyl-<italic toggle="yes">N</italic>-acetylgalactosaminyl-proteoglycan 4-beta-<italic toggle="yes">N</italic>-acetylgalactosaminyltransferase<break/>activity</td><td rowspan="1" colspan="1">.011050055</td><td rowspan="1" colspan="1">CHPF</td></tr><tr><td rowspan="1" colspan="1">GO:0016594</td><td rowspan="1" colspan="1">Glycine binding</td><td rowspan="1" colspan="1">.020167647</td><td rowspan="1" colspan="1">GRIN3B</td></tr><tr><td rowspan="1" colspan="1">GO:0005520</td><td rowspan="1" colspan="1">Insulin-like growth factor binding</td><td rowspan="1" colspan="1">.027402792</td><td rowspan="1" colspan="1">IGFALS</td></tr><tr><td rowspan="1" colspan="1">GO:0005520</td><td rowspan="1" colspan="1">Ionotropic glutamate receptor<break/>Activity</td><td rowspan="1" colspan="1">.031000847</td><td rowspan="1" colspan="1">GRIN3B</td></tr><tr><td rowspan="1" colspan="1">GO:0050750</td><td rowspan="1" colspan="1">Low-density lipoprotein particle<break/>Receptor binding</td><td rowspan="1" colspan="1">.041717483</td><td rowspan="1" colspan="1">APOE</td></tr><tr><td rowspan="1" colspan="1">GO:0032395</td><td rowspan="1" colspan="1">MHC class II receptor activity</td><td rowspan="1" colspan="1">.018350695</td><td rowspan="1" colspan="1">HLA-DQB1</td></tr><tr><td rowspan="1" colspan="1">GO:0032395</td><td rowspan="1" colspan="1">NMDA glutamate receptor activity</td><td rowspan="1" colspan="1">.014706953</td><td rowspan="1" colspan="1">GRIN3B</td></tr><tr><td rowspan="10" colspan="1">GO cellular component</td><td rowspan="1" colspan="1">GO:0042627</td><td rowspan="1" colspan="1">Chylomicron</td><td rowspan="1" colspan="1">.018350695</td><td rowspan="1" colspan="1">APOE</td></tr><tr><td rowspan="1" colspan="1">GO:0045334</td><td rowspan="1" colspan="1">Clathrin-coated endocytic vesicle</td><td rowspan="1" colspan="1">5.19E-04</td><td rowspan="1" colspan="1">HLA-DPB1; APOE;HLA-DQB1</td></tr><tr><td rowspan="1" colspan="1">GO:0030669</td><td rowspan="1" colspan="1">Clathrin-coated endocytic vesicle<break/>Membrane</td><td rowspan="1" colspan="1">2.81E-04</td><td rowspan="1" colspan="1">HLA-DPB1; APOE;HLA-DQB1</td></tr><tr><td rowspan="1" colspan="1">GO:0030669</td><td rowspan="1" colspan="1">Clathrin-coated vesicle membrane</td><td rowspan="1" colspan="1">6.13E-04</td><td rowspan="1" colspan="1">HLA-DPB1; APOE;HLA-DQB1</td></tr><tr><td rowspan="1" colspan="1">GO:0030662</td><td rowspan="1" colspan="1">Coated vesicle membrane</td><td rowspan="1" colspan="1">1.43E-04</td><td rowspan="1" colspan="1">HLA-DPB1; HLA-C;HLA-DQB1</td></tr><tr><td rowspan="1" colspan="1">GO:0030134</td><td rowspan="1" colspan="1">COPII-coated ER to Golgi<break/>transport vesicle</td><td rowspan="1" colspan="1">4.18E-04</td><td rowspan="1" colspan="1">HLA-DPB1; HLA-C;HLA-DQB1</td></tr><tr><td rowspan="1" colspan="1">GO:0030659</td><td rowspan="1" colspan="1">Cytoplasmic vesicle membrane</td><td rowspan="1" colspan="1">.03283621</td><td rowspan="1" colspan="1">HLA-DPB1; HLA-C;HLA-DQB1</td></tr><tr><td rowspan="1" colspan="1">GO:0030139</td><td rowspan="1" colspan="1">Endocytic vesicle</td><td rowspan="1" colspan="1">.005096004</td><td rowspan="1" colspan="1">HLA-DPB1; APOE;HLA-DQB1</td></tr><tr><td rowspan="1" colspan="1">GO:0071682</td><td rowspan="1" colspan="1">Endocytic vesicle lumen</td><td rowspan="1" colspan="1">.038158147</td><td rowspan="1" colspan="1">APOE</td></tr><tr><td rowspan="1" colspan="1">GO:0030666</td><td rowspan="1" colspan="1">Endocytic vesicle membrane</td><td rowspan="1" colspan="1">2.02E-04</td><td rowspan="1" colspan="1">HLA-DPB1; HLA-C; APOE;HLA-DQB1</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn3-11779322231186481"><p>Abbreviation: GO, gene ontology ; MHC, major histocompatibility complex; ER, estrogen receptor. TAP, transporter associated with antigen processing; NMDA, N-methyl-D-aspartate; COPII, cytoplasmic coat protein complex-II.</p></fn></table-wrap-foot></table-wrap><p><xref rid="fig4-11779322231186481" ref-type="fig">Figure 4</xref> shows the top 20 pathways that were connected to COVID-19 and smoking status. The GO approach divides them into segments using the terms MF, BP, and CC, but we only consider the BP database of GO terminologies. Initially, 436 GO terms were discovered to be shared by smokers and COVID-19 patients. The terms with a <italic toggle="yes">P</italic>-value under 0.05 were then added as the most important GO terms. Between the conditions, 159207 GO terminologies are discovered as the most enriched GO terms. The top 20 most important GO terms of the BP between COVID-19 and Smoking are summarized in <xref rid="fig5-11779322231186481" ref-type="fig">Figure 5</xref>. Biological (BP) and cellular processes are used in the GO approach.</p><fig position="float" id="fig4-11779322231186481" orientation="portrait"><label>Figure 4.</label><caption><p>Top 20 pathways are represented using a bubble plot that are associated with both conditions in transcriptomic analysis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-fig4.jpg"/></fig><fig position="float" id="fig5-11779322231186481" orientation="portrait"><label>Figure 5.</label><caption><p>The figure illustrates the protein-protein interactions between COVID-19 and smoking.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-fig5.jpg"/></fig></sec><sec id="section13-11779322231186481"><title>Protein-protein interactions (PPIs) analysis</title><p>We utilized our enriched gene sequences for common diseases to generate putative PPI networks by using web-based visualization techniques. The Cyto-Hubba<sup>
<xref rid="bibr50-11779322231186481" ref-type="bibr">50</xref>
</sup> was used to create the simplification PPI networks in order to determine the most significant hub proteins. Network Analyzer in Cytoscape was used to calculate the topological parameters,<sup>
<xref rid="bibr51-11779322231186481" ref-type="bibr">51</xref>
</sup> as shown in <xref rid="fig5-11779322231186481" ref-type="fig">Figure 5</xref>. The Maximal Clique Centrality (MCC), as well as BottleNeck algorithms, were used in conjunction with the CytoHubba plugin in Cytoscape to identify the highly linked hub proteins in the PPI network. Although more research is required to fully comprehend their roles, these recently discovered hub proteins may prove useful as therapeutic targets. This information confirms the inclusion of pertinent functional pathways and shows that the PPI subnetwork is present in our enriched gene sets. These hub proteins have been identified, but more research is needed to fully understand their functions. <xref rid="fig6-11779322231186481" ref-type="fig">Figures 6A</xref> and <xref rid="fig6-11779322231186481" ref-type="fig">B</xref> show the hub proteins that were discovered using the Bottleneck and MCC algorithms as previously mentioned. We obtained a total of 34 hub proteins; however, we have only reviewed 21 of them, only the top 3 being red, orange, and yellow. Using the MCC method, we were able to identify 17 hub proteins, of which 10 are considered to be the top hub proteins.</p><fig position="float" id="fig6-11779322231186481" orientation="portrait"><label>Figure 6.</label><caption><p>Hub proteins are identified using 2 different cyto-hubba algorithms called MCC and bottleneck to demonstrate the association between COVID-19 and smoking. (A) Bottleneck. (B) MCC.</p><p>MCC indicates maximal clique centrality.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-fig6.jpg"/></fig><p>In addition, using the BottleNeck algorithm, we found 17 hub proteins in total, with 11 of them being shown as the most important (marked as yellow, red, and orange colors). We have identified 14 important, distinct hub proteins across both algorithms, and they are as follows: C4A, SKIV2L, HLA-C, KRR1, UTP15, HLA&#8212;DQB, WDR46, UTP6, BCAR1, UTP3, NTSR1, NFKBIL 1, APOE, and NTS. Both algorithms share 7 of these proteins, including C4A, SKIV2L, HLA-C, KRR1, UTP15, and HLA-DQB. This information shows that the PPI subnetwork is present in our enriched gene sets and confirms the presence of relevant functional pathways. Although more research is required to fully understand their functions, the identified hub proteins may be helpful for treating STRING<sup>
<xref rid="bibr51-11779322231186481" ref-type="bibr">51</xref>
</sup> targets via the network. <xref rid="table3-11779322231186481" ref-type="table">Table 3</xref> displays a summary of important hub proteins.</p><table-wrap position="float" id="table3-11779322231186481" orientation="portrait"><label>Table 3.</label><caption><p>Summary of COVID-19 and smoking hub proteins identified by the algorithms of MCC and bottleneck.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-table3.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Protein symbol</th><th align="left" rowspan="1" colspan="1">Description</th><th align="left" rowspan="1" colspan="1">Features</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">C4A</td><td rowspan="1" colspan="1">Complement Component 4A (Rodgers Blood Group)</td><td rowspan="1" colspan="1">It results in the contraction of smooth muscle, and an increase in vascular permeability, as well as the histamine released from mast cells and basophilic leukocytes.</td></tr><tr><td rowspan="1" colspan="1">SKIV2L</td><td rowspan="1" colspan="1">Helicase SKI2W</td><td rowspan="1" colspan="1">Diseases associated with SKIV2L include Trichohepatoenteric Syndrome 2 and Trichohepatoenteric Syndrome 1</td></tr><tr><td rowspan="1" colspan="1">HLA-C</td><td rowspan="1" colspan="1">Class I, C, Major Histocompatibility Complex</td><td rowspan="1" colspan="1">infection with SARS-CoV-2 and Class I MHC-mediated antigen production process as well as presentation are 2 examples of its related processes.</td></tr><tr><td rowspan="1" colspan="1">KRR1</td><td rowspan="1" colspan="1">KRR1 Small Subunit Processome Component Homolog 2</td><td rowspan="1" colspan="1">Diseases associated with KRR1 include Duodenum Adenoma and Colorectal Cancer, Hereditary Nonpolyposis, Type 7</td></tr><tr><td rowspan="1" colspan="1">UTP15</td><td rowspan="1" colspan="1">UTP15 Small Subunit Processome Component</td><td rowspan="1" colspan="1">Diseases associated with UTP15 include North American Indian Childhood Cirrhosis and Basilar Artery Occlusion.</td></tr><tr><td rowspan="1" colspan="1">HLA -DQB</td><td rowspan="1" colspan="1">Major histocompatibility complex, class II, DQ beta 1</td><td rowspan="1" colspan="1">they form a functional protein complex called an antigen-binding DQ?? Heterodimer</td></tr><tr><td rowspan="1" colspan="1">WDR46</td><td rowspan="1" colspan="1">WD Repeat Domain 46</td><td rowspan="1" colspan="1">WDR46 is linked to conditions such as asthma, nasal polyps, as well as aspirin intolerance.</td></tr><tr><td rowspan="1" colspan="1">UTP6</td><td rowspan="1" colspan="1">Small Subunit Processome Component</td><td rowspan="1" colspan="1">Interstitial keratitis and Chromosome 17Q11.2 Removal Syndrome were also 2 conditions connected to UTP6.</td></tr><tr><td rowspan="1" colspan="1">BCAR1</td><td rowspan="1" colspan="1">BCAR1 Scaffold Protein, Cas Family Member</td><td rowspan="1" colspan="1">Diseases associated with BCAR1 include Estrogen Resistance and Cerebral Hypoxia</td></tr><tr><td rowspan="1" colspan="1">UTP3</td><td rowspan="1" colspan="1">UTP3 Small Subunit Processome Component</td><td rowspan="1" colspan="1">Manufacturing of Capped Intron-Containing Pre-mRNA and rRNA Processing in the Nucleus and Cytoplasm are 2 pathways that overlap with it.</td></tr><tr><td rowspan="1" colspan="1">NTSR1</td><td rowspan="1" colspan="1">Neurotensin Receptor 1</td><td rowspan="1" colspan="1">Diseases associated with NTSR1 include Suprasellar Meningioma and Neurilemmoma Of The Fifth Cranial Nerve</td></tr><tr><td rowspan="1" colspan="1">NFKBIL 1</td><td rowspan="1" colspan="1">GeneCards Symbol: NFKBIL1</td><td rowspan="1" colspan="1">Diseases associated with NFKBIL1 include Rheumatoid Arthritis and Arthritis.</td></tr><tr><td rowspan="1" colspan="1">APOE</td><td rowspan="1" colspan="1">Apolipoprotein E</td><td rowspan="1" colspan="1">It is necessary for the regular breakdown of the components of triglyceride-rich lipoproteins and binds to a particular liver and peripheral tissue receptor</td></tr><tr><td rowspan="1" colspan="1">NTS</td><td rowspan="1" colspan="1">Neurotensin</td><td rowspan="1" colspan="1">Diseases associated with NTS include Dumping Syndrome and Duodenogastric Reflux</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn4-11779322231186481"><p>Abbreviations: MMC, maximal clique centrality; mRNA, messenger RNA; rRNA, ribosomal RNA.</p></fn></table-wrap-foot></table-wrap></sec><sec id="section14-11779322231186481"><title>Identification of transcriptional and post-transcriptional regulators of the differentially expressed genes</title><p>TFs are proteins that regulate genes as well as transcriptional expression over all living things. TFs play an important role to control gene and transcriptional expression in all living things. All cellular processes depend on the activity of transcription factors (TFs),<sup>
<xref rid="bibr52-11779322231186481" ref-type="bibr">52</xref>
</sup> which is essential. We used Net-workAnalyst to analyze TFs and gene-microRNA interactions tools.<sup>
<xref rid="bibr37-11779322231186481" ref-type="bibr">37</xref>
</sup> miRNAs are non-coding short RNA molecules that control gene expression after transcription. By using the ChIP-X<sup>
<xref rid="bibr53-11779322231186481" ref-type="bibr">53</xref>
</sup> as well as JASPAR<sup>
<xref rid="bibr54-11779322231186481" ref-type="bibr">54</xref>
</sup> databases, the TFs-Gene network was created. The network of gene-miRNA interactions was created using NetworkAnalyst and the TarBase<sup>
<xref rid="bibr55-11779322231186481" ref-type="bibr">55</xref>
</sup> and miRTarBase<sup>
<xref rid="bibr56-11779322231186481" ref-type="bibr">56</xref>
</sup> databases. <xref rid="fig7-11779322231186481" ref-type="fig">Figure 7</xref> visually represents the TF-Gene Interactions and the regulator genes are KLC3, SKIV2L, CHPF, CYP2W1, C4A, TFC19, EGFL7, BCAR1, NFKBIL1, PTGER1, PLXNB3, GRIN3B, APOE, GAS2L1, GP1BB, PITX1, ZBTB33, MAZ, NTSRI, TOX2, GP1BB, HLA-DQBI, IGFALS, NKFBIL1, BCAR1, CHPF, HINFP, USF2, GATA2, TAFA2A, E2F6, TFA2C, YY1, STAT1, FOXC1, STAT3, NFKB1, and RELA were identified as the key regulators of the identified DEGs. Gene interactions involving miRNA are shown graphically in <xref rid="fig8-11779322231186481" ref-type="fig">Figure 8</xref>: C4A, SKIV2L, NFKBIL 1, CHPF, GRIN3B, IGFALS, GP1BB, GAS2L1, APOE, BCAR1, TRIM27, PLXNB3, EGFL7, NR2F1, ZBTB33, SP1, GLIS2, MYNN, MAZ, BCL11B TOX2, NFKB, TCF19, CHPF, CYP2W1, NPW, BCAR1, LMNTD2, IGFALS, NFIC, USF2, TFAP2A, E2F6, YY1, FOXCI, NFKBI, SREBF1, RELA, and GATA2.</p><fig position="float" id="fig7-11779322231186481" orientation="portrait"><label>Figure 7.</label><caption><p>TF-gene interactions showed using 2 different algorithms called ChEA and Jaspar to illustrate the linking between COVID-19 and smoking. (A) Encode. (B) JASPAR.</p><p>miRNA indicates microRNA.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-fig7.jpg"/></fig><fig position="float" id="fig8-11779322231186481" orientation="portrait"><label>Figure 8.</label><caption><p>Gene miRNA is identified between COVID-19 and smoking using 2 different algorithms called TarBase and MirTarBase. (A) Tar-Base. (B) Mir-Tar-Base.</p><p>miRNA indicates microRNA.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-fig8.jpg"/></fig></sec><sec id="section15-11779322231186481"><title>Drug-protein interaction</title><p>The protein&#8211;drug interactions for Smokers as well as a COVID-19 side effect and Common Genes are shown graphically in <xref rid="fig9-11779322231186481" ref-type="fig">Figure 9</xref> as follows: GRIN3B. The genes are connected to drugs called phenobarbital halothane, orphenadrine, secobarbital, atomoxetine, pen-tobarbital, acamprosate, gavestinel, tenocyclidine, dehydropiandroseterone, ketabemidone, glycine, L-glutamic acid, minacipran, and gabapentin.</p><fig position="float" id="fig9-11779322231186481" orientation="portrait"><label>Figure 9.</label><caption><p>The figure shows the protein drug interaction between COVID-19 and smoking using protein drug interaction algorithm.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-fig9.jpg"/></fig></sec></sec><sec sec-type="discussion" id="section16-11779322231186481"><title>Discussion</title><p>COVID-19 provides a significant threat to the general people while smoking remarkably raises the risk of both COVID-19 and mortality.<sup>
<xref rid="bibr57-11779322231186481" ref-type="bibr">57</xref>
</sup> Mainly, smoking is primarily responsible for suffering from acute COVID-19 consequences.<sup>
<xref rid="bibr7-11779322231186481" ref-type="bibr">7</xref>
</sup> COVID-19 sufferers who smoke regularly are in danger of developing various complications or diseases. So, in our study, we use several bioinformatics methods to discover genetic links between COVID-19 and smoking. Furthermore, our predicted medications can be considered to treat COVID-19 patients with a smoking history and doctors will encourage their patients to abstain from smoking. Undoubtedly, this will reduce the risk that people would develop COVID-19 or other complications brought on by smoking in COVID-19 patients. The bioinformatics method helps us to understand the mechanisms of underlying diseases.</p><p>COVID-19 patients have C4A (Complement Component 4A) accumulation in the lung tissue<sup><xref rid="bibr58-11779322231186481" ref-type="bibr">58</xref>,<xref rid="bibr59-11779322231186481" ref-type="bibr">59</xref></sup> and due to active smoking brain, C4A explication can be raised.<sup>
<xref rid="bibr60-11779322231186481" ref-type="bibr">60</xref>
</sup> C4A, which are wide immunologic activators, are known to encourage a number of immune processes, such as immune cell chemotaxis as well as NETosis, reactive oxygen species, also the production of cytokines, inflammasomes, and eicosanoids. These immune processes are playing an important role in a number of respiratory damages in COVID-19 patients.<sup>
<xref rid="bibr61-11779322231186481" ref-type="bibr">61</xref>
</sup> SKIV2L genes were observed to have significant associations with the presence of RPD, and the RPD rate was higher among patients with a history of smoking.<sup>
<xref rid="bibr62-11779322231186481" ref-type="bibr">62</xref>
</sup> It illustrated that SKIV2L included in the RNA exosome-activating SKI complex, limits baseline type I IFN accounts, which all are instigated by RNA sensors in circumstances where SKIV2L is deficient. Moreover, SARS-CoV-2 replication is restricted by pharmacological prohibition of the SKI intricate.<sup>
<xref rid="bibr63-11779322231186481" ref-type="bibr">63</xref>
</sup> It has been proposed that the enzymatic SKI complex subunit, SKIV2L, controls the IFN reactions by modulating RIG-I, which may indicate COVID-19 patient mortality.<sup>
<xref rid="bibr64-11779322231186481" ref-type="bibr">64</xref>
</sup> Patients succumb to COVID-19 quickly because there aren&#8217;t any early IFN responses against SARS-CoV-2.<sup>
<xref rid="bibr65-11779322231186481" ref-type="bibr">65</xref>
</sup></p><p>At first, we focused on 5 different pathways namely, the endothelial cell adhesion pathway, ER-phagosome pathway, neuroactive ligand-receptor interaction pathway, intestinal immune network pathway, and human cytomegalovirus infection pathway. In the endothelial cell, raised manifestation adhesion molecules are connected to COVID-19 patients.<sup>
<xref rid="bibr66-11779322231186481" ref-type="bibr">66</xref>
</sup> Two types of infection that causes severe acute respiratory syndrome can trigger the release of cytokines, activating the endothelial cells pathway. This could result in vascular changes, which are endothelial dysfunction, pyroptosis, and thrombosis usually mentioned to COVID-19.<sup>
<xref rid="bibr67-11779322231186481" ref-type="bibr">67</xref>
</sup> And in the vascular cell, patients with coronary heart disease who smoke experience higher plasma levels of adhesion molecule-1.<sup>
<xref rid="bibr68-11779322231186481" ref-type="bibr">68</xref>
</sup> Furthermore, phagosome pathways, besides inflammasomes, were discovered in the lung infected by SARS-CoV-2.<sup><xref rid="bibr69-11779322231186481" ref-type="bibr">69</xref>,<xref rid="bibr70-11779322231186481" ref-type="bibr">70</xref></sup> ER-phagosome pathway protein-binding AU-rich elements control mRNA stability in COVID-19 patients<sup>
<xref rid="bibr71-11779322231186481" ref-type="bibr">71</xref>
</sup> as well as the phagosomal pathway was enriched in smokers.<sup>
<xref rid="bibr72-11779322231186481" ref-type="bibr">72</xref>
</sup> Moreover, the KEGG-neuroactive ligand-receptor interconnection pathway demonstrated momentous relations with lung cancer related to smoking.<sup>
<xref rid="bibr73-11779322231186481" ref-type="bibr">73</xref>
</sup> In addition, in COVID-19 patients, the neuroactive ligand-receptor interaction pathway is one of the important pathways of 5 remarkably high-regulated pathways.<sup>
<xref rid="bibr74-11779322231186481" ref-type="bibr">74</xref>
</sup> According to molecular docking, 2 protein of coronavirus had a good affinity for the neuroactive ligand-receptor interconnection pathway.<sup>
<xref rid="bibr75-11779322231186481" ref-type="bibr">75</xref>
</sup> Notably, the symptoms of COVID-19, which can be controlled by the calcium signaling pathway and neuroactive ligand-receptor interaction pathway, include myalgias, headaches, and abdominal pain.<sup>
<xref rid="bibr76-11779322231186481" ref-type="bibr">76</xref>
</sup> COVID-19 sufferers could grow severe signs, namely high pathway, &#8220;intestinal-immune-network&#8221; for IgA production, and &#8220;T-cell-receptor signaling pathway.&#8221;<sup>
<xref rid="bibr77-11779322231186481" ref-type="bibr">77</xref>
</sup> The immune systems of COVID-19 patients&#8217; oral cavity and intestinal tract are controlled by serum IgA and secretory (s-)IgA.<sup>
<xref rid="bibr78-11779322231186481" ref-type="bibr">78</xref>
</sup> The effect of smoking produces the small intestine&#8217;s mucosal IgA antibody. It was found that genes highly connected with the immune-network involved in IgA-production signaling pathways included in the end part of the tiny intestine after exposure to cigarette smoke.<sup>
<xref rid="bibr79-11779322231186481" ref-type="bibr">79</xref>
</sup> And KEGG-pathway-enrichment easily concluded in 156 pathways associated with COVID-19, and the human cytomegalovirus infection pathway is one of them.<sup>
<xref rid="bibr80-11779322231186481" ref-type="bibr">80</xref>
</sup> Human cytomegalovirus infection pathways are related to the regulation of inflammation of COVID-19 patients.<sup>
<xref rid="bibr81-11779322231186481" ref-type="bibr">81</xref>
</sup> Also, smokers have a higher tendency to be infected by human cytomegalovirus infection pathway.<sup>
<xref rid="bibr82-11779322231186481" ref-type="bibr">82</xref>
</sup></p><p>In the hub-protein interaction, we have validated total of 7 proteins with previous literature named WDR46, C4A, APOE, HLA-C, HLA-DQB1, BCAR1, and NTS. Smoking and WDR46 interaction may be responsible for impacting young people&#8217;s lung development, which may affect the development of lung cancer in adults.<sup>
<xref rid="bibr83-11779322231186481" ref-type="bibr">83</xref>
</sup> Moreover, lungs from severe Significant C4a deposits were found in COVID-19 patients, which may indicate that complement plays a role in lung damage.<sup>
<xref rid="bibr84-11779322231186481" ref-type="bibr">84</xref>
</sup> In COVID-19 patients with severe there is strong immunohistochemical staining for C4a as well as C3, and also MAC that colocalizes with SARS-CoV-2 nucleocapsid protein.<sup>
<xref rid="bibr85-11779322231186481" ref-type="bibr">85</xref>
</sup> As well as, smoking expands the declaration of the C4A gene.<sup>
<xref rid="bibr60-11779322231186481" ref-type="bibr">60</xref>
</sup> We also discover that smoking expands the declaration of the C4A in the brain. It&#8217;s interesting to note that smoking is linked to diffuse as well as epidemiological evidence, and also dose-dependent cortical thinning suggests that smoking increases the risk of developing schizophrenia.<sup>
<xref rid="bibr60-11779322231186481" ref-type="bibr">60</xref>
</sup></p><p>According to previous the sensitivity and also cruelty of COVID-19 are associated with a number of genetic variables, including APOE.<sup>
<xref rid="bibr86-11779322231186481" ref-type="bibr">86</xref>
</sup> In the case category, APOE-associated comorbidities were danger factors for intense COVID-19. Another in vitro research discovered that SARS-CoV-2 endocytic entry was increased in cholesterol-loaded cells using the cholesterol transport protein APOE.<sup>
<xref rid="bibr86-11779322231186481" ref-type="bibr">86</xref>
</sup> The Apoe-isoform-dependent effect may aid in describing the elevated risk for severe COVID-19. By applying health data and also genetic data from the Biobank of the United Kingdom, current research has demonstrated where the Apoe E4/4 genotype grows the danger for intense COVID-19, in comparison to the ApoE3/3 genotype, independent of preexisting comorbidities, including cardiovascular diseases, type 2 diabetes as well as dementia, this suggests an association between ApoE4 and COVID-19.<sup>
<xref rid="bibr87-11779322231186481" ref-type="bibr">87</xref>
</sup> Also, the genotype of APOE e4 may potentially be related to smoking cessation.<sup>
<xref rid="bibr88-11779322231186481" ref-type="bibr">88</xref>
</sup> APOE genes are used in developing the danger of ischemic heart disease highly related to the active smokers.<sup>
<xref rid="bibr89-11779322231186481" ref-type="bibr">89</xref>
</sup> In addition, HLA-C loci are crucial in controlling how severe COVID-19 disease is clinically.<sup>
<xref rid="bibr90-11779322231186481" ref-type="bibr">90</xref>
</sup> HLA-C carriers are more likely to experience COVID-19&#8217;s severe clinical course. After Comparing with other HLA-alleles, it was highlighted that HLA-C has lower predicted binding sites for pertinent SARS-CoV-2 peptides.<sup>
<xref rid="bibr91-11779322231186481" ref-type="bibr">91</xref>
</sup> HLA-C was remarkably linked to COVID-19 patients&#8217; most severe disease, necessitating admission to an ICU.<sup>
<xref rid="bibr92-11779322231186481" ref-type="bibr">92</xref>
</sup> And passive smoking and HLA DQB1 positive were risk factors for narcolepsy.<sup>
<xref rid="bibr93-11779322231186481" ref-type="bibr">93</xref>
</sup> We postulated that let-7c-ADRB1-HLA-DQB1-AS1 interconnections are important in the development of smoking-related chronic obstructive pulmonary disease (COPD).<sup>
<xref rid="bibr94-11779322231186481" ref-type="bibr">94</xref>
</sup> In people with the HLA DQB1 gene, passive smoking may raise the risk of progressing narcolepsy.<sup>
<xref rid="bibr95-11779322231186481" ref-type="bibr">95</xref>
</sup> In COVID-19 patients, NTS may contribute to the severe aggravation of pulmonary edema, and microvascular clotting.<sup>
<xref rid="bibr96-11779322231186481" ref-type="bibr">96</xref>
</sup> There are different kinds of chemokines and cytokines are attracted NTs which also raised in infections of SARS-CoV-2, recommending a potential role for NTs in the defense opposed to SARS-CoV-2. In contrast, SARS-CoV-2 can circumlocutorily activate the development of neutrophil extracellular traps (NETs) in COVID-19 by inducing CS and also down-regulating ACE2, which prevents NTs-infiltrations.<sup>
<xref rid="bibr97-11779322231186481" ref-type="bibr">97</xref>
</sup> BCAR1 is associated with cigarette smoking and lung cancer.<sup>
<xref rid="bibr98-11779322231186481" ref-type="bibr">98</xref>
</sup> In cases of adenocarcinoma or squamous carcinoma in former or current smokers, BCAR1-mRNA levels predicted a worse prognosis. Breast cancer with high BCAR1 levels has a poor prognosis and is more likely to relapse.<sup>
<xref rid="bibr99-11779322231186481" ref-type="bibr">99</xref>
</sup> In addition, lung cancer patients with upregulated BCAR1 had a worse prognosis and had a big risk of distant metastasis, lymph node metastasis, and chemotherapy resistance.<sup>
<xref rid="bibr100-11779322231186481" ref-type="bibr">100</xref>
</sup></p><p>For drug-protein interaction, by previous literature, we were able to validate a total of 7 drugs, namely halothane, atomoxetine, acamprosate, glycin, minalcipran, gabapentin, and dehydroepiandrosterone (DHEA). halothane is a volatile anesthetic agent. The antiviral effect of volatile agents is one of the most significant effects when considering the possibility that they can treat COVID-19 acute respiratory distress syndrome (ARDS). Exposure to halothane at a concentration of 2.2% mildly inhibited the replication of many animal viruses.<sup>
<xref rid="bibr101-11779322231186481" ref-type="bibr">101</xref>
</sup> Where halothane inhibits the dimerization of the SARS-COV-2 encoded nucleocapsid protein.<sup>
<xref rid="bibr102-11779322231186481" ref-type="bibr">102</xref>
</sup> Patients with attention deficit hyperactivity disorder (ADHD) who take non-stimulant medications (such as viloxazine, as well as atomoxetine, also clonidine, and guanfacine), have a cancer diagnosis or were in palliative care at all point before their index the COVID-19 virus.<sup>
<xref rid="bibr103-11779322231186481" ref-type="bibr">103</xref>
</sup> Atomoxetine is, according to previous literature, remarkable growth in pulse as well as in blood pressure (BP).<sup>
<xref rid="bibr104-11779322231186481" ref-type="bibr">104</xref>
</sup> In addition, COVID-19 patients typically take atomoxetine 10&#8201;mg once a day to treat their depression as well as attention deficit disorder, and the dose was gradually increased to 40&#8201;mg.<sup>
<xref rid="bibr105-11779322231186481" ref-type="bibr">105</xref>
</sup> According to research, sodium acamprosate had a strongly prohibited task as opposed to 3CLpro from SARS-CoV-1, exposing an inhibition amount of more than 85%.<sup>
<xref rid="bibr106-11779322231186481" ref-type="bibr">106</xref>
</sup> As well as, acamprosate, a modulator of human GABRA1 protein, is in Phase IV as a part of the combination drug acamprosate and escitalopram as components of treatment for alcohol abuse.<sup>
<xref rid="bibr107-11779322231186481" ref-type="bibr">107</xref>
</sup> The US Food and Drug Administration (FDA) granted acamprosate permission in the United States in 2004 for the therapy of alcoholism. Both metabotropic glutamate receptors and <italic toggle="yes">N</italic>-methyl-<italic toggle="yes">d</italic>-aspartic acid channels are affected by acamprosate.<sup>
<xref rid="bibr108-11779322231186481" ref-type="bibr">108</xref>
</sup> The use of acamprosate calcium can be resisted SARS coronavirus.<sup>
<xref rid="bibr106-11779322231186481" ref-type="bibr">106</xref>
</sup> In another research, glycine is a non-essential amino acid that is being studied as a positive mitigator of cell damage and proinflammatory storms in COVID-19 patients. Two possible medications, glycine as well as pyridoxal, target the pathogenesis-related biomarkers of COVID-19 that we identified.<sup>
<xref rid="bibr109-11779322231186481" ref-type="bibr">109</xref>
</sup> The elevated thrombotic risk linked to COVID-19 may be practically reduced by high-dose glycine.<sup>
<xref rid="bibr110-11779322231186481" ref-type="bibr">110</xref>
</sup> Potential interactions between COVID-19 treatments, milnacipran and vortioxetine, will be deemed less risky.<sup>
<xref rid="bibr111-11779322231186481" ref-type="bibr">111</xref>
</sup> Using the L1000FWD web-based application, analysis of medications possibly helpful for treating COVID-19 patients who also have T2D was done on the 35 high-regulated and 14 low-regulated genes shared by COVID-19 infected pancreas organoids and Type-2 Diabetes islets. Vemurafenib, milnacipran, and abstain-analog were the 3 leading medications with the highest anti-similar signal.<sup>
<xref rid="bibr112-11779322231186481" ref-type="bibr">112</xref>
</sup> In this select group of patients with chronic persistent pain for a year or longer after knee arthroplasty, milnacipran reported decreased pain and some indications of functional development, demonstrating the necessity for well-powered investigations.<sup>
<xref rid="bibr113-11779322231186481" ref-type="bibr">113</xref>
</sup> In 2013, discernible difference in efficacy and tolerability.<sup>
<xref rid="bibr114-11779322231186481" ref-type="bibr">114</xref>
</sup> Milnacipran has been demonstrated to improve transmission in the descending pain pathways, reducing pain intensity and stiffness and enhancing function.<sup>
<xref rid="bibr115-11779322231186481" ref-type="bibr">115</xref>
</sup> We utilized 50&#8201;mg of tramadol, 100&#8201;mg of gabapentin every night, 30&#8201;mg of duloxetine twice a day, and ketorolac as needed to treat pain in a clinical trial. The patients who are suffering from COVID-19&#8221; pain crisis&#8221; had resolved by week 4, but still had acute pain scored as 4-6/10. The patient experienced ongoing myalgia as well as numbness, tingling, and weakness. We retained the dose of duloxetine at 30&#8201;mg 2 times daily while raising gabapentin to 200&#8201;mg every night. By week 6, the patient&#8217;s neuropathic discomfort had disappeared.<sup>
<xref rid="bibr116-11779322231186481" ref-type="bibr">116</xref>
</sup> The gabapentin dosage was raised to 400&#8201;mg per night. Moreover, a second negative result came from the SARS-Cov-2 test. Though gabapentin is used in COVID-19 patients, gabapentin increases the risk of kidney injury in COVID-19 patients. So, adjust the gabapentin dose based on renal function.<sup>
<xref rid="bibr116-11779322231186481" ref-type="bibr">116</xref>
</sup> As information from the previous study, DHEA sulfate has a function in COVID-19 prognosis, and therapy <sup>
<xref rid="bibr117-11779322231186481" ref-type="bibr">117</xref>
</sup> and DHEA is used to treat ARDS in COVID-19 sufferers.<sup>
<xref rid="bibr118-11779322231186481" ref-type="bibr">118</xref>
</sup> signs of COVID-19 that are severe seem to be more likely in people with higher levels of circulating androgens. To see if low serum testosterone levels have an impact on COVID-19 infections and their severity. Dehydroepiandrosterone is being used as a booster of COVID-19 treatment.<sup>
<xref rid="bibr119-11779322231186481" ref-type="bibr">119</xref>
</sup> Considering the COVID-19 epidemic, DHEA is a potent inhibitor of glucose-6-phosphate dehydrogenase (G6PD), because it has been demonstrated that a decrease in G6PD activity makes human cells more susceptible to coronavirus 229E infections.<sup>
<xref rid="bibr117-11779322231186481" ref-type="bibr">117</xref>
</sup> And, DHEA, a recognized antiviral drug, levels play an important role in newborns&#8217; defense against COV-19.<sup>
<xref rid="bibr120-11779322231186481" ref-type="bibr">120</xref>
</sup> A sigma-1 receptor agonist, DHEA, is a testosterone precursor. Dehydroepiandrosterone, the substances for the sigma-1 and sigma-2 receptors, were effective inhibitors of SARS-CoV-2 replication.<sup>
<xref rid="bibr121-11779322231186481" ref-type="bibr">121</xref>
</sup> Furthermore, DHEA may counteract the anti-inflammatory effects of glucocorticoids used to treat severe COVID-19 complications.<sup>
<xref rid="bibr122-11779322231186481" ref-type="bibr">122</xref>
</sup> Dehydroepiandrosterone immune response mechanism, which could provide new therapeutic insights for the subset of COVID-19 patients who experience cutaneous manifestations.<sup>
<xref rid="bibr123-11779322231186481" ref-type="bibr">123</xref>
</sup> All of our results have been validated against the scholarly literature as much as feasible. For this reason, there is hush opportunity for more in vivo and in vitro level research as it was not possible. A physician may advise current smokers to quit based on these results to reduce the severity danger of COVID-19. It&#8217;s possible that the pharmaceutical industry, using the resulting chemical molecule, may create medications to treat people with COVID-19 with a smoking history. It is important to emphasize that the smaller sample sizes of the datasets are a drawback of our research. This analysis didn&#8217;t take into consideration age, sex, race, or any other possibly relevant factors. Therefore, additional validation is required to carefully examine the biological remarkable of the problem as indicated in this work as shown in <xref rid="table4-11779322231186481" ref-type="table">Table 4</xref>.</p><table-wrap position="float" id="table4-11779322231186481" orientation="portrait"><label>Table 4.</label><caption><p>Previous research has validated the identified potential target genes or biomarkers that are related to smoking as well as COVID-19.</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_11779322231186481-table4.jpg"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Gene</th><th align="left" rowspan="1" colspan="1">Smoking</th><th align="left" rowspan="1" colspan="1">COVID-19</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">WDR46</td><td rowspan="1" colspan="1">(132)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">C4A</td><td rowspan="1" colspan="1">(133)</td><td rowspan="1" colspan="1">(85)</td></tr><tr><td rowspan="1" colspan="1">APOE</td><td rowspan="1" colspan="1">91</td><td rowspan="1" colspan="1">89</td></tr><tr><td rowspan="1" colspan="1">HLA-C</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">(93)</td></tr><tr><td rowspan="1" colspan="1">HLA-DQB1</td><td rowspan="1" colspan="1">(96)</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">BCAR1</td><td rowspan="1" colspan="1">(101)</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">NTS</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">(134)</td></tr></tbody></table></alternatives></table-wrap></sec><sec sec-type="conclusions" id="section17-11779322231186481"><title>Conclusion</title><p>In this study, we used several bioinformatics approaches to learn more about the connection between smoking and the intensity of COVID-19. The transcriptomic analysis of our study revealed 37 shared molecular marker DEGs between T2D and smokers. Whereas 7 genes (WDR46, C4A, APOE, HLA-C, HLA-DQB1, BCAR1, and NTS) are validated using previous studies. Signaling pathways such as the Endothelial Cell adhesion pathway, ER-phagosome pathway, neuroactive ligand-receptor interaction pathway, intestinal immune network pathway, and human cytomegalovirus infection pathway is also verified using published literature. Also, we have validated 7 drugs named halothane, atomoxetine, acamprosate, glycin, minalcipran, gabapentin, and DHEA. There are several surprising new findings that open up possibilities for investigation. Finally, our research recommends that smokers should abort smoking to reduce the terrible impact of COVID-19. However, using our study based on drug prediction results, it would be possible to invent new drugs for COVID-19 patients with a smoking history.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The author(s) received no financial support for the research, authorship, and/or publication of this article.</p></fn><fn fn-type="COI-statement"><p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn><fn fn-type="con"><p><bold>Author Contributions:</bold> Md Anisur Rahman, Md Al Amin, Most Nilufa Yeasmin, Md Zahidul Islam: data collection, conceptualization, methodology, software, validation, formal analysis, investigation, resources, data curation, writing&#8212;original draft preparation, writing&#8212;review and editing, visualization, supervision, project administration. All authors contributed to the article and approved the submitted version.</p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-11779322231186481"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohamadian</surname><given-names>M</given-names></name><name name-style="western"><surname>Chiti</surname><given-names>H</given-names></name><name name-style="western"><surname>Shoghli</surname><given-names>A</given-names></name><name name-style="western"><surname>Biglari</surname><given-names>S</given-names></name><name name-style="western"><surname>Parsamanesh</surname><given-names>N</given-names></name><name name-style="western"><surname>Esmaeilzadeh</surname><given-names>A</given-names></name></person-group>. <article-title>COVID-19: virology, biology and novel laboratory diagnosis</article-title>. <source>J Gene Med</source>. <year>2021</year>;<volume>23</volume>:e3303.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jgm.3303</pub-id><pub-id pub-id-type="pmcid">PMC7883242</pub-id><pub-id pub-id-type="pmid">33305456</pub-id></mixed-citation></ref><ref id="bibr2-11779322231186481"><label>2</label><mixed-citation publication-type="webpage"><collab>World Health Organization</collab>. <article-title>Smoking and COVID-19</article-title>. Scientific brief. Published June 30, 2020. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Smoking-2020.2" ext-link-type="uri">https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Smoking-2020.2</ext-link></mixed-citation></ref><ref id="bibr3-11779322231186481"><label>3</label><mixed-citation publication-type="journal"><collab>World Health Organization</collab>. <article-title>SARS-CoV-2</article-title>. <year>2022</year>. Smoking and COVID-19 (who.int).</mixed-citation></ref><ref id="bibr4-11779322231186481"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>L</given-names></name></person-group>. <article-title>Covid-19: true global death toll from pandemic is almost 15 million, says WHO</article-title>. <source>BMJ</source>. <year>2022</year>;<volume>377</volume>:<fpage>o1144</fpage>.<pub-id pub-id-type="pmid">35523437</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.o1144</pub-id></mixed-citation></ref><ref id="bibr5-11779322231186481"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kevadiya</surname><given-names>B</given-names></name><name name-style="western"><surname>Machhi</surname><given-names>J</given-names></name><name name-style="western"><surname>Herskovitz</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>Diagnostics for SARS-CoV-2 infections</article-title>. <source>Nat Mater</source>. <year>2021</year>;<volume>20</volume>:<fpage>593</fpage>-<lpage>605</lpage>.<pub-id pub-id-type="pmid">33589798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41563-020-00906-z</pub-id><pub-id pub-id-type="pmcid">PMC8264308</pub-id></mixed-citation></ref><ref id="bibr6-11779322231186481"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Long</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name></person-group>, <etal>et al</etal>. <article-title>Tobacco smoking confers risk for severe COVID-19 unexplainable by pulmonary imaging</article-title>. <source>J Intern Med</source>. <year>2021</year>;<volume>289</volume>:<fpage>574</fpage>-<lpage>583</lpage>.<pub-id pub-id-type="pmid">33270312</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/joim.13190</pub-id><pub-id pub-id-type="pmcid">PMC7753648</pub-id></mixed-citation></ref><ref id="bibr7-11779322231186481"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eisenberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Eisenberg</surname><given-names>M</given-names></name></person-group>. <article-title>Smoking cessation during the COVID-19 epidemic</article-title>. <source>Nicotine Tob Res</source>. <year>2020</year>;<volume>22</volume>:<fpage>1664</fpage>-<lpage>1665</lpage>.<pub-id pub-id-type="pmid">32363386</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ntr/ntaa075</pub-id><pub-id pub-id-type="pmcid">PMC7239173</pub-id></mixed-citation></ref><ref id="bibr8-11779322231186481"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haddad</surname><given-names>C</given-names></name><name name-style="western"><surname>Bou Malhab</surname><given-names>S</given-names></name><name name-style="western"><surname>Sacre</surname><given-names>H</given-names></name><name name-style="western"><surname>Salameh</surname><given-names>P</given-names></name></person-group>. <article-title>Smoking and COVID-19: a scoping review</article-title>. <source>Tob Use Insights</source>. <year>2021</year>;<volume>14</volume>:1179173X21994612.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1179173X21994612</pub-id><pub-id pub-id-type="pmcid">PMC7890709</pub-id><pub-id pub-id-type="pmid">33642886</pub-id></mixed-citation></ref><ref id="bibr9-11779322231186481"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aoshiba</surname><given-names>K</given-names></name><name name-style="western"><surname>Nagai</surname><given-names>A</given-names></name></person-group>. <article-title>Oxidative stress, cell death, and other damage to alveolar epithelial cells induced by cigarette smoke</article-title>. <source>Tob Induc Dis</source>. <year>2003</year>;<volume>1</volume>:<fpage>219</fpage>-<lpage>226</lpage>.<pub-id pub-id-type="pmid">19570263</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1617-9625-1-3-219</pub-id><pub-id pub-id-type="pmcid">PMC2671551</pub-id></mixed-citation></ref><ref id="bibr10-11779322231186481"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>SL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XM</given-names></name><name name-style="western"><surname>Feng</surname><given-names>YG</given-names></name></person-group>, <etal>et al</etal>. <article-title>Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer</article-title>. <source>Med Hypotheses</source>. <year>2020</year>;<volume>143</volume>:<fpage>110074</fpage>.<pub-id pub-id-type="pmid">32645661</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mehy.2020.110074</pub-id><pub-id pub-id-type="pmcid">PMC7333600</pub-id></mixed-citation></ref><ref id="bibr11-11779322231186481"><label>11</label><mixed-citation publication-type="webpage"><collab>World Health Organization</collab>. <article-title>Tobacco and waterpipe use increases the risk of suffering from COVID-19</article-title>. Published 2020. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.emro.who.int/tfi/know-the-truth/tobacco-and-waterpipe-users-are-at-increased-risk-of-covid-19-infection.html#:~:text=Since%20waterpipe%20smoking%20is%20typically,COVID%2D19%20in%20social%20gatherings" ext-link-type="uri">https://www.emro.who.int/tfi/know-the-truth/tobacco-and-waterpipe-users-are-at-increased-risk-of-covid-19-infection.html#:~:text=Since%20waterpipe%20smoking%20is%20typically,COVID%2D19%20in%20social%20gatherings</ext-link></mixed-citation></ref><ref id="bibr12-11779322231186481"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>H</given-names></name></person-group>. <article-title>Sex difference and smoking predisposition in patients with COVID-19</article-title>. <source>Lancet Respir Med</source>. <year>2020</year>;<volume>8</volume>:e20.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-2600(20)30117-X</pub-id><pub-id pub-id-type="pmcid">PMC7103991</pub-id><pub-id pub-id-type="pmid">32171067</pub-id></mixed-citation></ref><ref id="bibr13-11779322231186481"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>L</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa</article-title>. <source>Int J Oral Sci</source>. <year>2020</year>;<volume>12</volume>:<fpage>8</fpage>.<pub-id pub-id-type="pmid">32094336</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41368-020-0074-x</pub-id><pub-id pub-id-type="pmcid">PMC7039956</pub-id></mixed-citation></ref><ref id="bibr14-11779322231186481"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kashyap</surname><given-names>V</given-names></name><name name-style="western"><surname>Dhasmana</surname><given-names>A</given-names></name><name name-style="western"><surname>Massey</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Smoking and COVID-19: adding fuel to the flame</article-title>. <source>Int J Mol Sci</source>. <year>2020</year>;<volume>21</volume>:<fpage>6581</fpage>.<pub-id pub-id-type="pmid">32916821</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21186581</pub-id><pub-id pub-id-type="pmcid">PMC7555793</pub-id></mixed-citation></ref><ref id="bibr15-11779322231186481"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salah</surname><given-names>H</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>T</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>J</given-names></name></person-group>. <article-title>Smoking doubles the mortality risk in COVID-19: a meta-analysis of recent reports and potential mechanisms</article-title>. <source>Cureus</source>. <year>2020</year>;<volume>12</volume>:e10837.<pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.10837</pub-id><pub-id pub-id-type="pmcid">PMC7647838</pub-id><pub-id pub-id-type="pmid">33173643</pub-id></mixed-citation></ref><ref id="bibr16-11779322231186481"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>U&#287;ur Chousein</surname><given-names>EG</given-names></name><name name-style="western"><surname>&#199;&#246;rt&#252;k</surname><given-names>M</given-names></name><name name-style="western"><surname>C&#305;narka</surname><given-names>H</given-names></name></person-group>, <etal>et al</etal>. <article-title>Is there any effect of smoking status on severity and mortality of hospitalized patients with COVID-19 pneumonia?</article-title><source>Tuberk Toraks</source>. <year>2020</year>;<volume>68</volume>:<fpage>371</fpage>-<lpage>378</lpage>.<pub-id pub-id-type="pmid">33448734</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5578/tt.70352</pub-id></mixed-citation></ref><ref id="bibr17-11779322231186481"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamaguchi</surname><given-names>NH</given-names></name></person-group>. <article-title>Smoking, immunity, and DNA damage</article-title>. <source>Transl Lung Cancer Res</source>. <year>2019</year>;<volume>8</volume>:S3-S6.<pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/tlcr.2019.03.02</pub-id><pub-id pub-id-type="pmcid">PMC6546629</pub-id><pub-id pub-id-type="pmid">31211100</pub-id></mixed-citation></ref><ref id="bibr18-11779322231186481"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mustard</surname><given-names>J</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>E</given-names></name></person-group>. <article-title>Effect of smoking on blood coagulation and platelet survival in man</article-title>. <source>Br Med J</source>. <year>1963</year>;<volume>1</volume>:<fpage>846</fpage>.<pub-id pub-id-type="pmid">13936891</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.1.5334.846</pub-id><pub-id pub-id-type="pmcid">PMC2122719</pub-id></mixed-citation></ref><ref id="bibr19-11779322231186481"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luque-Ram&#237;rez</surname><given-names>M</given-names></name><name name-style="western"><surname>Mendieta-Azcona</surname><given-names>C</given-names></name><name name-style="western"><surname>del Rey S&#225;nchez</surname><given-names>JM</given-names></name><name name-style="western"><surname>Mat&#237;es</surname><given-names>M</given-names></name><name name-style="western"><surname>Escobar-Morreale</surname><given-names>HF</given-names></name></person-group>. <article-title>Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking</article-title>. <source>Eur J Endocrinol</source>. <year>2009</year>;<volume>160</volume>:<fpage>469</fpage>-<lpage>480</lpage>.<pub-id pub-id-type="pmid">19139031</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1530/EJE-08-0725</pub-id></mixed-citation></ref><ref id="bibr20-11779322231186481"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corr&#234;a</surname><given-names>TD</given-names></name><name name-style="western"><surname>Cordioli</surname><given-names>RL</given-names></name><name name-style="western"><surname>Campos Guerra</surname><given-names>JC</given-names></name></person-group>, <etal>et al</etal>. <article-title>Coagulation profile of COVID-19 patients admitted to the ICU: an exploratory study</article-title>. <source>PLoS ONE</source>. <year>2020</year>;<volume>15</volume>:e0243604.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0243604</pub-id><pub-id pub-id-type="pmcid">PMC7737963</pub-id><pub-id pub-id-type="pmid">33320874</pub-id></mixed-citation></ref><ref id="bibr21-11779322231186481"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sherry</surname><given-names>S</given-names></name><name name-style="western"><surname>Ward</surname><given-names>M</given-names></name><name name-style="western"><surname>Kholodov</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>DbSNP: the NCBI database of genetic variation</article-title>. <source>Nucleic Acids Res</source>. <year>2001</year>;<volume>29</volume>:<fpage>308</fpage>-<lpage>311</lpage>.<pub-id pub-id-type="pmid">11125122</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/29.1.308</pub-id><pub-id pub-id-type="pmcid">PMC29783</pub-id></mixed-citation></ref><ref id="bibr22-11779322231186481"><label>22</label><mixed-citation publication-type="gov"><collab>NCBI and GEO-NCBI</collab>. Published 2022. <comment>Accessed June 28, 2023</comment>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/geo/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/geo/</ext-link></mixed-citation></ref><ref id="bibr23-11779322231186481"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arunachalam</surname><given-names>PS</given-names></name><name name-style="western"><surname>Wimmers</surname><given-names>F</given-names></name><name name-style="western"><surname>Mok</surname><given-names>CKP</given-names></name></person-group>, <etal>et al</etal>. <article-title>Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans</article-title>. <source>Science</source>. <year>2020</year>;<volume>369</volume>:<fpage>1210</fpage>-<lpage>1220</lpage>.<pub-id pub-id-type="pmid">32788292</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.abc6261</pub-id><pub-id pub-id-type="pmcid">PMC7665312</pub-id></mixed-citation></ref><ref id="bibr24-11779322231186481"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Strulovici-Barel</surname><given-names>Y</given-names></name></person-group>, <etal>et al</etal>. <article-title>Role of OSGIN1 in mediating smoking-induced autophagy in the human airway epithelium</article-title>. <source>Autophagy</source>. <year>2017</year>;<volume>13</volume>:<fpage>1205</fpage>-<lpage>1220</lpage>.<pub-id pub-id-type="pmid">28548877</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15548627.2017.1301327</pub-id><pub-id pub-id-type="pmcid">PMC5529077</pub-id></mixed-citation></ref><ref id="bibr25-11779322231186481"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahi</surname><given-names>NA</given-names></name><name name-style="western"><surname>Najafabadi</surname><given-names>MF</given-names></name><name name-style="western"><surname>Pilarczyk</surname><given-names>M</given-names></name><name name-style="western"><surname>Kouril</surname><given-names>M</given-names></name><name name-style="western"><surname>Medvedovic</surname><given-names>M</given-names></name></person-group>. <article-title>GREIN: an interactive web platform for re-analyzing GEO RNA-seq data</article-title>. <source>Sci Rep</source>. <year>2019</year>;<volume>9</volume>:<fpage>7580</fpage>.<pub-id pub-id-type="pmid">31110304</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-43935-8</pub-id><pub-id pub-id-type="pmcid">PMC6527554</pub-id></mixed-citation></ref><ref id="bibr26-11779322231186481"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Love</surname><given-names>MI</given-names></name><name name-style="western"><surname>Huber</surname><given-names>W</given-names></name><name name-style="western"><surname>Anders</surname><given-names>S</given-names></name></person-group>. <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source>. <year>2014</year>;<volume>15</volume>:<fpage>550</fpage>.<pub-id pub-id-type="pmid">25516281</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmcid">PMC4302049</pub-id></mixed-citation></ref><ref id="bibr27-11779322231186481"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barab&#225;si</surname><given-names>A</given-names></name><name name-style="western"><surname>Gulbahce</surname><given-names>N</given-names></name><name name-style="western"><surname>Loscalzo</surname><given-names>J</given-names></name></person-group>. <article-title>Network medicine: a network-based approach to human disease</article-title>. <source>Nat Rev Genet</source>. <year>2011</year>;<volume>12</volume>:<fpage>56</fpage>-<lpage>68</lpage>.<pub-id pub-id-type="pmid">21164525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrg2918</pub-id><pub-id pub-id-type="pmcid">PMC3140052</pub-id></mixed-citation></ref><ref id="bibr28-11779322231186481"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wysocki</surname><given-names>K</given-names></name><name name-style="western"><surname>Ritter</surname><given-names>L</given-names></name></person-group>. <article-title>Diseasome: an approach to understanding gene-disease interactions</article-title>. <source>Annu Rev Nurs Res</source>. <year>2011</year>;<volume>29</volume>:<fpage>55</fpage>-<lpage>72</lpage>.<pub-id pub-id-type="pmid">22891498</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1891/0739-6686.29.55</pub-id></mixed-citation></ref><ref id="bibr29-11779322231186481"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Langhauser</surname><given-names>F</given-names></name><name name-style="western"><surname>Casas</surname><given-names>AI</given-names></name><name name-style="western"><surname>Dao</surname><given-names>VT</given-names></name></person-group>, <etal>et al</etal>. <article-title>A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection</article-title>. <source>npj Syst Biol Appl</source>. <year>2018</year>;<volume>4</volume>:<fpage>8</fpage>.<pub-id pub-id-type="pmid">29423274</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41540-017-0039-7</pub-id><pub-id pub-id-type="pmcid">PMC5799370</pub-id></mixed-citation></ref><ref id="bibr30-11779322231186481"><label>30</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name name-style="western"><surname>Lopes</surname><given-names>J</given-names></name><name name-style="western"><surname>Domingues</surname><given-names>B</given-names></name></person-group>. <article-title>PharmGKB Network&#8211;Integrating Diseaseome, Pharmacome and Targetome</article-title>. <year>2007</year>. <pub-id pub-id-type="doi">10.13140/RG.2.1.4634.1847</pub-id></mixed-citation></ref><ref id="bibr31-11779322231186481"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>T</given-names></name><name name-style="western"><surname>Shafi</surname><given-names>A</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>T</given-names></name><name name-style="western"><surname>Draghici</surname><given-names>S</given-names></name></person-group>. <article-title>Identifying significantly impacted pathways: a comprehensive review and assessment</article-title>. <source>Genome Biol</source>. <year>2019</year>;<volume>20</volume>:<fpage>203</fpage>.<pub-id pub-id-type="pmid">31597578</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13059-019-1790-4</pub-id><pub-id pub-id-type="pmcid">PMC6784345</pub-id></mixed-citation></ref><ref id="bibr32-11779322231186481"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>A</given-names></name><name name-style="western"><surname>Kuleshov</surname><given-names>MV</given-names></name></person-group>, <etal>et al</etal>. <article-title>Gene set knowledge discovery with Enrichr</article-title>. <source>Curr Protoc</source>. <year>2021</year>;<volume>1</volume>:e90.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cpz1.90</pub-id><pub-id pub-id-type="pmcid">PMC8152575</pub-id><pub-id pub-id-type="pmid">33780170</pub-id></mixed-citation></ref><ref id="bibr33-11779322231186481"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Young</surname><given-names>MD</given-names></name><name name-style="western"><surname>Wakefield</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>GK</given-names></name><name name-style="western"><surname>Oshlack</surname><given-names>A</given-names></name></person-group>. <article-title>Gene ontology analysis for RNA-seq: accounting for selection bias</article-title>. <source>Genome Biol</source>. <year>2010</year>;<volume>11</volume>:R14.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/gb-2010-11-2-r14</pub-id><pub-id pub-id-type="pmcid">PMC2872874</pub-id><pub-id pub-id-type="pmid">20132535</pub-id></mixed-citation></ref><ref id="bibr34-11779322231186481"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ge</surname><given-names>S</given-names></name><name name-style="western"><surname>Son</surname><given-names>E</given-names></name><name name-style="western"><surname>Yao</surname><given-names>R</given-names></name></person-group>. <article-title>iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data</article-title>. <source>BMC Bioinformatics</source>. <year>2018</year>;<volume>19</volume>:<fpage>534</fpage>.<pub-id pub-id-type="pmid">30567491</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12859-018-2486-6</pub-id><pub-id pub-id-type="pmcid">PMC6299935</pub-id></mixed-citation></ref><ref id="bibr35-11779322231186481"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Safari-Alighiarloo</surname><given-names>N</given-names></name><name name-style="western"><surname>Taghizadeh</surname><given-names>M</given-names></name><name name-style="western"><surname>Rezaei-Tavirani</surname><given-names>M</given-names></name><name name-style="western"><surname>Goliaei</surname><given-names>B</given-names></name><name name-style="western"><surname>Peyvandi</surname><given-names>AA</given-names></name></person-group>. <article-title>Protein-protein interaction networks (PPI) and complex diseases</article-title>. <source>Gastroenterol Hepatol Bed Bench</source>. <year>2014</year>;<volume>7</volume>:<fpage>17</fpage>-<lpage>31</lpage>.<pub-id pub-id-type="pmid">25436094</pub-id><pub-id pub-id-type="pmcid">PMC4017556</pub-id></mixed-citation></ref><ref id="bibr36-11779322231186481"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szklarczyk</surname><given-names>D</given-names></name><name name-style="western"><surname>Franceschini</surname><given-names>A</given-names></name><name name-style="western"><surname>Kuhn</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored</article-title>. <source>Nucleic Acids Res</source>. <year>2010</year>;<volume>39</volume>:D561-D568.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkq973</pub-id><pub-id pub-id-type="pmcid">PMC3013807</pub-id><pub-id pub-id-type="pmid">21045058</pub-id></mixed-citation></ref><ref id="bibr37-11779322231186481"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>G</given-names></name><name name-style="western"><surname>Soufan</surname><given-names>O</given-names></name><name name-style="western"><surname>Ewald</surname><given-names>J</given-names></name><name name-style="western"><surname>Hancock</surname><given-names>REW</given-names></name><name name-style="western"><surname>Basu</surname><given-names>N</given-names></name><name name-style="western"><surname>Xia</surname><given-names>J</given-names></name></person-group>. <article-title>NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis</article-title>. <source>Nucleic Acids Res</source>. <year>2019</year>;<volume>47</volume>:W234-W241.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkz240</pub-id><pub-id pub-id-type="pmcid">PMC6602507</pub-id><pub-id pub-id-type="pmid">30931480</pub-id></mixed-citation></ref><ref id="bibr38-11779322231186481"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Ma</surname><given-names>B</given-names></name><name name-style="western"><surname>Nussinov</surname><given-names>R</given-names></name></person-group>. <article-title>Protein&#8211;protein interaction networks: how can a hub protein bind so many different partners?</article-title><source>Trends Biochem Sci</source>. <year>2009</year>;<volume>34</volume>:<fpage>594</fpage>-<lpage>600</lpage>.<pub-id pub-id-type="pmid">19837592</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tibs.2009.07.007</pub-id><pub-id pub-id-type="pmcid">PMC7292551</pub-id></mixed-citation></ref><ref id="bibr39-11779322231186481"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guzzi</surname><given-names>PH</given-names></name><name name-style="western"><surname>Di Martino</surname><given-names>MT</given-names></name><name name-style="western"><surname>Tagliaferri</surname><given-names>P</given-names></name><name name-style="western"><surname>Tassone</surname><given-names>P</given-names></name><name name-style="western"><surname>Cannataro</surname><given-names>M</given-names></name></person-group>. <article-title>Analysis of miRNA, mRNA, and TF interactions through network-based methods</article-title>. <source>EURASIP J Bioinform Syst Biol</source>. <year>2015</year>;<volume>2015</volume>:<fpage>4</fpage>.<pub-id pub-id-type="pmid">28194173</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13637-015-0023-8</pub-id><pub-id pub-id-type="pmcid">PMC5270379</pub-id></mixed-citation></ref><ref id="bibr40-11779322231186481"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>SL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>SY</given-names></name></person-group>. <article-title>Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer</article-title>. <source>PLoS ONE</source>. <year>2018</year>;<volume>13</volume>:e0198055.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0198055</pub-id><pub-id pub-id-type="pmcid">PMC6107126</pub-id><pub-id pub-id-type="pmid">30138363</pub-id></mixed-citation></ref><ref id="bibr41-11779322231186481"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fornes</surname><given-names>O</given-names></name><name name-style="western"><surname>Castro-Mondragon</surname><given-names>J</given-names></name><name name-style="western"><surname>Khan</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>JASPAR 2020: update of the open-access database of transcription factor binding profiles</article-title>. <source>Nucleic Acids Res</source>. <year>2020</year>;<volume>48</volume>:D87-D92.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkz1001</pub-id><pub-id pub-id-type="pmcid">PMC7145627</pub-id><pub-id pub-id-type="pmid">31701148</pub-id></mixed-citation></ref><ref id="bibr42-11779322231186481"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karagkouni</surname><given-names>D</given-names></name><name name-style="western"><surname>Paraskevopoulou</surname><given-names>M</given-names></name><name name-style="western"><surname>Chatzopoulos</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>. <article-title>DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA&#8211;gene interactions</article-title>. <source>Nucleic Acids Res</source>. <year>2018</year>;<volume>46</volume>:D239-D245.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkx1141</pub-id><pub-id pub-id-type="pmcid">PMC5753203</pub-id><pub-id pub-id-type="pmid">29156006</pub-id></mixed-citation></ref><ref id="bibr43-11779322231186481"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>miRTarBase 2020: updates to the experimentally validated microRNA&#8211;target interaction database</article-title>. <source>Nucleic Acids Res</source>. <year>2020</year>;<volume>48</volume>:D148-D154.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkz896</pub-id><pub-id pub-id-type="pmcid">PMC7145596</pub-id><pub-id pub-id-type="pmid">31647101</pub-id></mixed-citation></ref><ref id="bibr44-11779322231186481"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Otasek</surname><given-names>D</given-names></name><name name-style="western"><surname>Morris</surname><given-names>J</given-names></name><name name-style="western"><surname>Bou&#231;as</surname><given-names>J</given-names></name><name name-style="western"><surname>Pico</surname><given-names>A</given-names></name><name name-style="western"><surname>Demchak</surname><given-names>B</given-names></name></person-group>. <article-title>Cytoscape automation: empowering workflow-based network analysis</article-title>. <source>Genome Biol</source>. <year>2019</year>;<volume>20</volume>:<fpage>185</fpage>.<pub-id pub-id-type="pmid">31477170</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13059-019-1758-4</pub-id><pub-id pub-id-type="pmcid">PMC6717989</pub-id></mixed-citation></ref><ref id="bibr45-11779322231186481"><label>45</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Jude</surname><given-names>S</given-names></name><name name-style="western"><surname>Gopi</surname><given-names>S</given-names></name></person-group>. <part-title>Bioanalytical screening/purification techniques</part-title>. In: <person-group person-group-type="editor"><name name-style="western"><surname>Gopi</surname><given-names>S</given-names></name><name name-style="western"><surname>Amalraj</surname><given-names>A</given-names></name><name name-style="western"><surname>Jude</surname><given-names>S</given-names></name></person-group>, eds. <source>High-Resolution Mass Spectroscopy for Phytochemical Analysis</source>. <publisher-name>Apple Academic Press</publisher-name>; <volume>2021</volume>:<fpage>121</fpage>-<lpage>148</lpage>.</mixed-citation></ref><ref id="bibr46-11779322231186481"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hasan</surname><given-names>M</given-names></name><name name-style="western"><surname>Hossain</surname><given-names>M</given-names></name><name name-style="western"><surname>Bhuiyan</surname><given-names>P</given-names></name><name name-style="western"><surname>Miah</surname><given-names>M</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>M</given-names></name></person-group>. <article-title>A system biology approach to determine therapeutic targets by identifying molecular mechanisms and key pathways for type 2 diabetes that are linked to the development of tuberculosis and rheumatoid arthritis</article-title>. <source>Life Sci</source>. <year>2022</year>;<volume>297</volume>:<fpage>120483</fpage>.<pub-id pub-id-type="pmid">35288173</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2022.120483</pub-id></mixed-citation></ref><ref id="bibr47-11779322231186481"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Debnath</surname><given-names>P</given-names></name><name name-style="western"><surname>Bhaumik</surname><given-names>S</given-names></name><name name-style="western"><surname>Sen</surname><given-names>D</given-names></name><name name-style="western"><surname>Muttineni</surname><given-names>R</given-names></name><name name-style="western"><surname>Debnath</surname><given-names>S</given-names></name></person-group>. <article-title>Identification of SARS-CoV-2 main protease inhibitors using structure based virtual screening and molecular dynamics simulation of drugbank database</article-title>. <source>ChemistrySelect</source>. <year>2021</year>;<volume>6</volume>:<fpage>4991</fpage>-<lpage>5013</lpage>.<pub-id pub-id-type="pmid">34541295</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/slct.202100854</pub-id><pub-id pub-id-type="pmcid">PMC8441713</pub-id></mixed-citation></ref><ref id="bibr48-11779322231186481"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoo</surname><given-names>M</given-names></name><name name-style="western"><surname>Shin</surname><given-names>J</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>DSigDB: drug signatures database for gene set analysis</article-title>. <source>Bioinformatics</source>. <year>2015</year>;<volume>31</volume>:<fpage>3069</fpage>-<lpage>3071</lpage>.<pub-id pub-id-type="pmid">25990557</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/btv313</pub-id><pub-id pub-id-type="pmcid">PMC4668778</pub-id></mixed-citation></ref><ref id="bibr49-11779322231186481"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuleshov</surname><given-names>M</given-names></name><name name-style="western"><surname>Jones</surname><given-names>M</given-names></name><name name-style="western"><surname>Rouillard</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title>. <source>Nucleic Acids Res</source>. <year>2016</year>;<volume>44</volume>:W90-W97.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkw377</pub-id><pub-id pub-id-type="pmcid">PMC4987924</pub-id><pub-id pub-id-type="pmid">27141961</pub-id></mixed-citation></ref><ref id="bibr50-11779322231186481"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chin</surname><given-names>CH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>SH</given-names></name><name name-style="western"><surname>Wu</surname><given-names>HH</given-names></name><name name-style="western"><surname>Ho</surname><given-names>CW</given-names></name><name name-style="western"><surname>Ko</surname><given-names>MT</given-names></name><name name-style="western"><surname>Lin</surname><given-names>CY</given-names></name></person-group>. <article-title>cytoHubba: identifying hub objects and sub-networks from complex interactome</article-title>. <source>BMC Syst Biol</source>. <year>2014</year>;<volume>8</volume>:S11.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1752-0509-8-S4-S11</pub-id><pub-id pub-id-type="pmcid">PMC4290687</pub-id><pub-id pub-id-type="pmid">25521941</pub-id></mixed-citation></ref><ref id="bibr51-11779322231186481"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doncheva</surname><given-names>N</given-names></name><name name-style="western"><surname>Morris</surname><given-names>J</given-names></name><name name-style="western"><surname>Gorodkin</surname><given-names>J</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>L</given-names></name></person-group>. <article-title>Cytoscape StringApp: network analysis and visualization of proteomics data</article-title>. <source>J Proteome Res</source>. <year>2019</year>;<volume>18</volume>:<fpage>623</fpage>-<lpage>632</lpage>.<pub-id pub-id-type="pmid">30450911</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jproteome.8b00702</pub-id><pub-id pub-id-type="pmcid">PMC6800166</pub-id></mixed-citation></ref><ref id="bibr52-11779322231186481"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitsis</surname><given-names>T</given-names></name><name name-style="western"><surname>Efthimiadou</surname><given-names>A</given-names></name><name name-style="western"><surname>Bacopoulou</surname><given-names>F</given-names></name><name name-style="western"><surname>Vlachakis</surname><given-names>D</given-names></name><name name-style="western"><surname>Chrousos</surname><given-names>G</given-names></name><name name-style="western"><surname>Eliopoulos</surname><given-names>E</given-names></name></person-group>. <article-title>Transcription factors and evolution: an integral part of gene expression (Review)</article-title>. <source>World Acad Sci J</source>. <year>2020</year>;<volume>2</volume>:<fpage>3</fpage>-<lpage>8</lpage>.</mixed-citation></ref><ref id="bibr53-11779322231186481"><label>53</label><mixed-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Assad</surname><given-names>M</given-names></name><name name-style="western"><surname>Najam</surname><given-names>A</given-names></name><name name-style="western"><surname>Cheema</surname><given-names>H</given-names></name></person-group>. <article-title>GaN based high power SPDT switch for single chip X-band T/R module front-end</article-title>. <conf-name>Paper presented at: 2021 1st International Conference on Microwave, Antennas Circuits (ICMAC)</conf-name>; <conf-date>21-22 December, 2021</conf-date>; <conf-loc>Islamabad, Pakistan</conf-loc>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ieeexplore.ieee.org/document/9678237" ext-link-type="uri">https://ieeexplore.ieee.org/document/9678237</ext-link></mixed-citation></ref><ref id="bibr54-11779322231186481"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castro-Mondragon</surname><given-names>J</given-names></name><name name-style="western"><surname>Riudavets-Puig</surname><given-names>R</given-names></name><name name-style="western"><surname>Rauluseviciute</surname><given-names>I</given-names></name></person-group>, <etal>et al</etal>. <article-title>JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles</article-title>. <source>Nucleic Acids Res</source>. <year>2022</year>;<volume>50</volume>:D165-D173.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab1113</pub-id><pub-id pub-id-type="pmcid">PMC8728201</pub-id><pub-id pub-id-type="pmid">34850907</pub-id></mixed-citation></ref><ref id="bibr55-11779322231186481"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>MH</given-names></name><name name-style="western"><surname>Rana</surname><given-names>HK</given-names></name><name name-style="western"><surname>Peng</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>. <article-title>Bioinformatics and system biology approaches to identify pathophysiological impact of COVID-19 to the progression and severity of neurological diseases</article-title>. <source>Comput Biol Med</source>. <year>2021</year>;<volume>138</volume>:<fpage>104859</fpage>.<pub-id pub-id-type="pmid">34601390</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.compbiomed.2021.104859</pub-id><pub-id pub-id-type="pmcid">PMC8483812</pub-id></mixed-citation></ref><ref id="bibr56-11779322231186481"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parray</surname><given-names>A</given-names></name><name name-style="western"><surname>Mir</surname><given-names>F</given-names></name><name name-style="western"><surname>Doudin</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>SnoRNAs and miRNAs networks underlying COVID-19 disease severity</article-title>. <source>Vaccines</source>. <year>2021</year>;<volume>9</volume>:<fpage>1056</fpage>.<pub-id pub-id-type="pmid">34696164</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/vaccines9101056</pub-id><pub-id pub-id-type="pmcid">PMC8538251</pub-id></mixed-citation></ref><ref id="bibr57-11779322231186481"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patanavanich</surname><given-names>R</given-names></name><name name-style="western"><surname>Glantz</surname><given-names>S</given-names></name></person-group>. <article-title>Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: a systematic review and meta-analysis</article-title>. <source>BMC Public Health</source>. <year>2021</year>;<volume>21</volume>:<fpage>1554</fpage>.<pub-id pub-id-type="pmid">34399729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12889-021-11579-x</pub-id><pub-id pub-id-type="pmcid">PMC8366155</pub-id></mixed-citation></ref><ref id="bibr58-11779322231186481"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noris</surname><given-names>M</given-names></name><name name-style="western"><surname>Benigni</surname><given-names>A</given-names></name><name name-style="western"><surname>Remuzzi</surname><given-names>G</given-names></name></person-group>. <article-title>The case of complement activation in COVID-19 multiorgan impact</article-title>. <source>Kidney Int</source>. <year>2020</year>;<volume>98</volume>:<fpage>314</fpage>-<lpage>322</lpage>.<pub-id pub-id-type="pmid">32461141</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.kint.2020.05.013</pub-id><pub-id pub-id-type="pmcid">PMC7246017</pub-id></mixed-citation></ref><ref id="bibr59-11779322231186481"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bumiller-Bini</surname><given-names>V</given-names></name><name name-style="western"><surname>de Freitas Oliveira-Tor&#233;</surname><given-names>C</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>TM</given-names></name></person-group>, <etal>et al</etal>. <article-title>MASPs at the crossroad between the complement and the coagulation cascades-the case for COVID-19</article-title>. <source>Genet Mol Biol</source>. <year>2021</year>;<volume>44</volume>:e20200199.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/1678-4685-GMB-2020-0199</pub-id><pub-id pub-id-type="pmcid">PMC7982787</pub-id><pub-id pub-id-type="pmid">33729332</pub-id></mixed-citation></ref><ref id="bibr60-11779322231186481"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>M</given-names></name><name name-style="western"><surname>Haney</surname><given-names>JR</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name></person-group>, <etal>et al</etal>. <article-title>Brain gene co-expression networks link complement signaling with convergent synaptic pathology in schizophrenia</article-title>. <source>Nat Neurosci</source>. <year>2021</year>;<volume>24</volume>:<fpage>799</fpage>-<lpage>809</lpage>.<pub-id pub-id-type="pmid">33958802</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41593-021-00847-z</pub-id><pub-id pub-id-type="pmcid">PMC8178202</pub-id></mixed-citation></ref><ref id="bibr61-11779322231186481"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamal</surname><given-names>M</given-names></name><name name-style="western"><surname>Bangash</surname><given-names>HI</given-names></name><name name-style="western"><surname>Habiba</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Immune dysregulation and system pathology in COVID-19</article-title>. <source>Virulence</source>. <year>2021</year>;<volume>12</volume>:<fpage>918</fpage>-<lpage>936</lpage>.<pub-id pub-id-type="pmid">33757410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21505594.2021.1898790</pub-id><pub-id pub-id-type="pmcid">PMC7993139</pub-id></mixed-citation></ref><ref id="bibr62-11779322231186481"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altay</surname><given-names>L</given-names></name><name name-style="western"><surname>Liakopoulos</surname><given-names>S</given-names></name><name name-style="western"><surname>Berghold</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Genetic and environmental risk factors for reticular pseudodrusen in the EUGENDA study</article-title>. <source>Mol Vis</source>. <year>2021</year>;<volume>27</volume>:<fpage>757</fpage>-<lpage>767</lpage>.<pub-id pub-id-type="pmid">35136347</pub-id><pub-id pub-id-type="pmcid">PMC8763662</pub-id></mixed-citation></ref><ref id="bibr63-11779322231186481"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moll</surname><given-names>T</given-names></name><name name-style="western"><surname>Odon</surname><given-names>V</given-names></name><name name-style="western"><surname>Harvey</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal>. <article-title>Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication</article-title>. <source>Biorxiv</source>. <year>2022</year>. doi:<pub-id pub-id-type="doi">10.1101/2022.03.06.483172</pub-id><pub-id pub-id-type="pmcid">PMC9585911</pub-id><pub-id pub-id-type="pmid">36241425</pub-id></mixed-citation></ref><ref id="bibr64-11779322231186481"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weston</surname><given-names>S</given-names></name><name name-style="western"><surname>Baracco</surname><given-names>L</given-names></name><name name-style="western"><surname>Keller</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal>. <article-title>The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2020</year>;<volume>117</volume>:<fpage>30687</fpage>-<lpage>30698</lpage>.<pub-id pub-id-type="pmid">33184176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2012939117</pub-id><pub-id pub-id-type="pmcid">PMC7720140</pub-id></mixed-citation></ref><ref id="bibr65-11779322231186481"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramasamy</surname><given-names>S</given-names></name><name name-style="western"><surname>Subbian</surname><given-names>S</given-names></name></person-group>. <article-title>Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis</article-title>. <source>Clin Microbiol Rev</source>. <year>2021</year>;<volume>34</volume>:e00299-20.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CMR.00299-20</pub-id><pub-id pub-id-type="pmcid">PMC8142516</pub-id><pub-id pub-id-type="pmid">33980688</pub-id></mixed-citation></ref><ref id="bibr66-11779322231186481"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tong</surname><given-names>M</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xia</surname><given-names>D</given-names></name></person-group>, <etal>et al</etal>. <article-title>Elevated expression of serum endothelial cell adhesion molecules in COVID-19 patients</article-title>. <source>J Infect Dis</source>. <year>2020</year>;<volume>222</volume>:<fpage>894</fpage>-<lpage>898</lpage>.<pub-id pub-id-type="pmid">32582936</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jiaa349</pub-id><pub-id pub-id-type="pmcid">PMC7337874</pub-id></mixed-citation></ref><ref id="bibr67-11779322231186481"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagashima</surname><given-names>S</given-names></name><name name-style="western"><surname>Mendes</surname><given-names>MC</given-names></name><name name-style="western"><surname>Camargo Martins</surname><given-names>AP</given-names></name></person-group>, <etal>et al</etal>. <article-title>Endothelial dysfunction and thrombosis in patients with COVID-19&#8212;brief report</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2020</year>;<volume>40</volume>:<fpage>2404</fpage>-<lpage>2407</lpage>.<pub-id pub-id-type="pmid">32762443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/ATVBAHA.120.314860</pub-id><pub-id pub-id-type="pmcid">PMC7505138</pub-id></mixed-citation></ref><ref id="bibr68-11779322231186481"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavusoglu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Timuralp</surname><given-names>B</given-names></name><name name-style="western"><surname>Us</surname><given-names>T</given-names></name></person-group>, <etal>et al</etal>. <article-title>Cigarette smoking increases plasma concentrations of vascular cell adhesion molecule-1 in patients with coronary artery disease</article-title>. <source>Angiology</source>. <year>2004</year>;<volume>55</volume>:<fpage>397</fpage>-<lpage>402</lpage>.<pub-id pub-id-type="pmid">15258685</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/000331970405500406</pub-id></mixed-citation></ref><ref id="bibr69-11779322231186481"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>ABMMK</given-names></name><name name-style="western"><surname>Khan</surname><given-names>MA</given-names></name></person-group>. <article-title>Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>19395</fpage>.<pub-id pub-id-type="pmid">33173052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-020-76404-8</pub-id><pub-id pub-id-type="pmcid">PMC7656460</pub-id></mixed-citation></ref><ref id="bibr70-11779322231186481"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name></person-group>, <etal>et al</etal>. <article-title>The proteomic characteristics of airway mucus from critically ill COVID-19 patients</article-title>. <source>Life Sci</source>. <year>2021</year>;<volume>269</volume>:<fpage>119046</fpage>.<pub-id pub-id-type="pmid">33453245</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2021.119046</pub-id><pub-id pub-id-type="pmcid">PMC7806453</pub-id></mixed-citation></ref><ref id="bibr71-11779322231186481"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ibrahim</surname><given-names>IH</given-names></name><name name-style="western"><surname>Ellakwa</surname><given-names>DE</given-names></name></person-group>. <article-title>SUMO pathway, blood coagulation and oxidative stress in SARS-CoV-2 infection</article-title>. <source>Biochem Biophys Rep</source>. <year>2021</year>;<volume>26</volume>:<fpage>100938</fpage>.<pub-id pub-id-type="pmid">33558851</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrep.2021.100938</pub-id><pub-id pub-id-type="pmcid">PMC7857074</pub-id></mixed-citation></ref><ref id="bibr72-11779322231186481"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><name name-style="western"><surname>Kohler</surname><given-names>M</given-names></name><name name-style="western"><surname>Heyder</surname><given-names>T</given-names></name></person-group>, <etal>et al</etal>. <article-title>Long-term smoking alters abundance of over half of the proteome in bronchoalveolar lavage cell in smokers with normal spirometry, with effects on molecular pathways associated with COPD</article-title>. <source>Respir Res</source>. <year>2018</year>;<volume>19</volume>:<fpage>40</fpage>.<pub-id pub-id-type="pmid">29514648</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12931-017-0695-6</pub-id><pub-id pub-id-type="pmcid">PMC5842534</pub-id></mixed-citation></ref><ref id="bibr73-11779322231186481"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>X</given-names></name><name name-style="western"><surname>Boss&#233;</surname><given-names>Y</given-names></name><name name-style="western"><surname>Landi</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk</article-title>. <source>Nat Commun</source>. <year>2018</year>;<volume>9</volume>:<fpage>3221</fpage>.<pub-id pub-id-type="pmid">30104567</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-018-05074-y</pub-id><pub-id pub-id-type="pmcid">PMC6089967</pub-id></mixed-citation></ref><ref id="bibr74-11779322231186481"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name></person-group>, <etal>et al</etal>. <article-title>Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19</article-title>. <source>Synth Syst Biotechnol</source>. <year>2021</year>;<volume>6</volume>:<fpage>135</fpage>-<lpage>143</lpage>.<pub-id pub-id-type="pmid">34151035</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.synbio.2021.06.002</pub-id><pub-id pub-id-type="pmcid">PMC8200311</pub-id></mixed-citation></ref><ref id="bibr75-11779322231186481"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YK</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name></person-group>, <etal>et al</etal>. <article-title>Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming</article-title>. <source>Biomed Pharmacother</source>. <year>2020</year>;<volume>129</volume>:<fpage>110281</fpage>.<pub-id pub-id-type="pmid">32554251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2020.110281</pub-id><pub-id pub-id-type="pmcid">PMC7247521</pub-id></mixed-citation></ref><ref id="bibr76-11779322231186481"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>K</given-names></name></person-group>. <article-title>Is acupuncture effective in the treatment of COVID-19 related symptoms? Based on bioinformatics/network topology strategy</article-title>. <source>Brief Bioinform</source>. <year>2021</year>;<volume>22</volume>:bbab110.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bib/bbab110</pub-id><pub-id pub-id-type="pmcid">PMC8083275</pub-id><pub-id pub-id-type="pmid">33866350</pub-id></mixed-citation></ref><ref id="bibr77-11779322231186481"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Chan</surname><given-names>MTV</given-names></name><name name-style="western"><surname>Wu</surname><given-names>WKK</given-names></name></person-group>. <article-title>Bioinformatic analyses suggest augmented interleukin-17 signaling as the mechanism of COVID-19-associated herpes zoster</article-title>. <source>Environ Sci Pollut Res Int</source>. <year>2021</year>;<volume>28</volume>:<fpage>65769</fpage>-<lpage>65775</lpage>.<pub-id pub-id-type="pmid">34322810</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11356-021-15567-x</pub-id><pub-id pub-id-type="pmcid">PMC8318549</pub-id></mixed-citation></ref><ref id="bibr78-11779322231186481"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watanabe</surname><given-names>S</given-names></name><name name-style="western"><surname>Naito</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>T</given-names></name></person-group>. <article-title>Host factors that aggravate COVID-19 pneumonia</article-title>. <source>Int J Fam Med Prim Care</source>. <year>2020</year>;<volume>1</volume>:<fpage>1011</fpage>.</mixed-citation></ref><ref id="bibr79-11779322231186481"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Pelgrim</surname><given-names>C</given-names></name><name name-style="western"><surname>Peralta Marzal</surname><given-names>L</given-names></name></person-group>, <etal>et al</etal>. <article-title>Changes in intestinal homeostasis and immunity in a cigarette smoke- and LPS-induced murine model for COPD: the lung-gut axis</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source>. <year>2022</year>;<volume>323</volume>:<fpage>L266</fpage>-<lpage>L280</lpage>.<pub-id pub-id-type="pmid">35699290</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajplung.00486.2021</pub-id><pub-id pub-id-type="pmcid">PMC9423728</pub-id></mixed-citation></ref><ref id="bibr80-11779322231186481"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qing-Lai</surname><given-names>L</given-names></name><name name-style="western"><surname>Ai-Wu</surname><given-names>L</given-names></name><name name-style="western"><surname>Miao-Yi</surname><given-names>H</given-names></name><name name-style="western"><surname>Xiao-Yu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wei-Yong</surname><given-names>W</given-names></name></person-group>. <article-title>Pharmacological mechanism and network pharmacology research of Huashibaidu formula in treating COVID-19</article-title>. <source>Nat Prod Res Dev</source>. <year>2020</year>;<volume>32</volume>:<fpage>909</fpage>.</mixed-citation></ref><ref id="bibr81-11779322231186481"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>You</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name></person-group>, <etal>et al</etal>. <article-title>Glycyrrhetinic acid: a potential drug for the treatment of COVID-19 cytokine storm</article-title>. <source>Phytomedicine</source>. <year>2022</year>;<volume>102</volume>:<fpage>154153</fpage>.<pub-id pub-id-type="pmid">35636166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2022.154153</pub-id><pub-id pub-id-type="pmcid">PMC9098921</pub-id></mixed-citation></ref><ref id="bibr82-11779322231186481"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foglio-Bonda</surname><given-names>PL</given-names></name><name name-style="western"><surname>Gabriele</surname><given-names>M</given-names></name><name name-style="western"><surname>Graziani</surname><given-names>F</given-names></name><name name-style="western"><surname>De Andrea</surname><given-names>M</given-names></name><name name-style="western"><surname>Mondini</surname><given-names>M</given-names></name><name name-style="western"><surname>Gariglio</surname><given-names>M</given-names></name></person-group>. <article-title>High prevalence of human cytomegalovirus in a population of periodontally healthy subjects</article-title>. <source>Med Oral Patol Oral Cir Bucal</source>. <year>2010</year>;<volume>15</volume>(<issue>2</issue>):e292-e296.<pub-id pub-id-type="doi" assigning-authority="pmc">10.4317/medoral.15.e292</pub-id><pub-id pub-id-type="pmid">20038920</pub-id></mixed-citation></ref><ref id="bibr83-11779322231186481"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>M</given-names></name><name name-style="western"><surname>Zang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Ma</surname><given-names>S</given-names></name></person-group>. <article-title>Accommodating missingness in environmental measurements in gene-environment interaction analysis</article-title>. <source>Genet Epidemiol</source>. <year>2017</year>;<volume>41</volume>:<fpage>523</fpage>-<lpage>554</lpage>.<pub-id pub-id-type="pmid">28657194</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/gepi.22055</pub-id><pub-id pub-id-type="pmcid">PMC5561007</pub-id></mixed-citation></ref><ref id="bibr84-11779322231186481"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKechnie</surname><given-names>J</given-names></name><name name-style="western"><surname>Blish</surname><given-names>C</given-names></name></person-group>. <article-title>The innate immune system: fighting on the front lines or fanning the flames of COVID-19?</article-title><source>Cell Host Microbe</source>. <year>2020</year>;<volume>27</volume>:<fpage>863</fpage>-<lpage>869</lpage>.<pub-id pub-id-type="pmid">32464098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chom.2020.05.009</pub-id><pub-id pub-id-type="pmcid">PMC7237895</pub-id></mixed-citation></ref><ref id="bibr85-11779322231186481"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Govender</surname><given-names>S</given-names></name><name name-style="western"><surname>Naicker</surname><given-names>T</given-names></name></person-group>. <article-title>The contribution of complement protein C1q in COVID-19 and HIV infection comorbid with preeclampsia: a review</article-title>. <source>Int Arch Allergy Immunol</source>. <year>2022</year>;<volume>183</volume>:<fpage>1114</fpage>-<lpage>1126</lpage>.<pub-id pub-id-type="pmid">35661665</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000524976</pub-id><pub-id pub-id-type="pmcid">PMC9393774</pub-id></mixed-citation></ref><ref id="bibr86-11779322231186481"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Shao</surname><given-names>L</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Z</given-names></name></person-group>, <etal>et al</etal>. <article-title>APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients</article-title>. <source>Signal Transduct Target Ther</source>. <year>2022</year>;<volume>7</volume>:<fpage>261</fpage>.<pub-id pub-id-type="pmid">35915083</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-022-01118-4</pub-id><pub-id pub-id-type="pmcid">PMC9340718</pub-id></mixed-citation></ref><ref id="bibr87-11779322231186481"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>G</given-names><suffix>Jr</suffix></name></person-group>, <etal>et al</etal>. <article-title>ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response</article-title>. <source>Cell Stem Cell</source>. <year>2021</year>;<volume>28</volume>:331-342.e5.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.stem.2020.12.018</pub-id><pub-id pub-id-type="pmcid">PMC7832490</pub-id><pub-id pub-id-type="pmid">33450186</pub-id></mixed-citation></ref><ref id="bibr88-11779322231186481"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalapatapu</surname><given-names>RK</given-names></name><name name-style="western"><surname>Delucchi</surname><given-names>KL</given-names></name></person-group>. <article-title>APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset</article-title>. <source>Am J Drug Alcohol Abuse</source>. <year>2013</year>;<volume>39</volume>:<fpage>219</fpage>-<lpage>226</lpage>.<pub-id pub-id-type="pmid">23808899</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00952990.2013.800084</pub-id><pub-id pub-id-type="pmcid">PMC3710309</pub-id></mixed-citation></ref><ref id="bibr89-11779322231186481"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zak</surname><given-names>I</given-names></name><name name-style="western"><surname>Niemiec</surname><given-names>P</given-names></name><name name-style="western"><surname>Balcerzyk</surname><given-names>A</given-names></name><name name-style="western"><surname>Krauze</surname><given-names>J</given-names></name></person-group>. <article-title>Combined &#8220;pro-atherosclerotic&#8221; variants of the ACE and APOE genes increase the risk of the coronary artery disease associated with the presence of cigarette smoking</article-title>. <source>Acta Cardiol</source>. <year>2008</year>;<volume>63</volume>:<fpage>741</fpage>-<lpage>747</lpage>.<pub-id pub-id-type="pmid">19157170</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2143/AC.63.6.2033392</pub-id></mixed-citation></ref><ref id="bibr90-11779322231186481"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guerini</surname><given-names>F</given-names></name><name name-style="western"><surname>Bolognesi</surname><given-names>E</given-names></name><name name-style="western"><surname>Lax</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>HLA allele frequencies and association with severity of COVID-19 infection in Northern Italian patients</article-title>. <source>Cells</source>. <year>2022</year>;<volume>11</volume>:<fpage>1792</fpage>.<pub-id pub-id-type="pmid">35681490</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cells11111792</pub-id><pub-id pub-id-type="pmcid">PMC9179900</pub-id></mixed-citation></ref><ref id="bibr91-11779322231186481"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiner</surname><given-names>J</given-names></name><name name-style="western"><surname>Suwalski</surname><given-names>P</given-names></name><name name-style="western"><surname>Holtgrewe</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01</article-title>. <source>EClinicalMedicine</source>. <year>2021</year>;<volume>40</volume>:<fpage>101099</fpage>.<pub-id pub-id-type="pmid">34490415</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eclinm.2021.101099</pub-id><pub-id pub-id-type="pmcid">PMC8410317</pub-id></mixed-citation></ref><ref id="bibr92-11779322231186481"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonaccorsi</surname><given-names>I</given-names></name><name name-style="western"><surname>Carrega</surname><given-names>P</given-names></name><name name-style="western"><surname>Venanzi Rullo</surname><given-names>E</given-names></name></person-group>, <etal>et al</etal>. <article-title>HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk</article-title>. <source>Immunol Lett</source>. <year>2021</year>;<volume>234</volume>:<fpage>44</fpage>-<lpage>46</lpage>.<pub-id pub-id-type="pmid">33905752</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.imlet.2021.04.007</pub-id><pub-id pub-id-type="pmcid">PMC8065245</pub-id></mixed-citation></ref><ref id="bibr93-11779322231186481"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pe&#345;inov&#225;</surname><given-names>P</given-names></name><name name-style="western"><surname>Feketeov&#225;</surname><given-names>E</given-names></name><name name-style="western"><surname>Kemlink</surname><given-names>D</given-names></name></person-group>, <etal>et al</etal>. <article-title>Smoking prevalence and its clinical correlations in patients with narcolepsy-cataplexy</article-title>. <source>Prague Med Rep</source>. <year>2016</year>;<volume>117</volume>:<fpage>81</fpage>-<lpage>89</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.14712/23362936.2016.8</pub-id><pub-id pub-id-type="pmid">27668524</pub-id></mixed-citation></ref><ref id="bibr94-11779322231186481"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mao</surname><given-names>ZD</given-names></name><name name-style="western"><surname>Shi</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Liu</surname><given-names>ZG</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name></person-group>. <article-title>Comprehensive analysis of miRNA-mRNA-lncRNA networks in non-smoking and smoking patients with chronic obstructive pulmonary disease</article-title>. <source>Cell Physiol Biochem</source>. <year>2018</year>;<volume>50</volume>:<fpage>1140</fpage>-<lpage>1153</lpage>.<pub-id pub-id-type="pmid">30355907</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000494541</pub-id></mixed-citation></ref><ref id="bibr95-11779322231186481"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ton</surname><given-names>TG</given-names></name><name name-style="western"><surname>Longstreth</surname><given-names>WT</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Koepsell</surname><given-names>T</given-names></name></person-group>. <article-title>Active and passive smoking and risk of narcolepsy in people with HLA DQB1*0602: a population-based case-control study</article-title>. <source>Neuroepidemiology</source>. <year>2009</year>;<volume>32</volume>:<fpage>114</fpage>-<lpage>121</lpage>.<pub-id pub-id-type="pmid">19039244</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000177037</pub-id><pub-id pub-id-type="pmcid">PMC2970624</pub-id></mixed-citation></ref><ref id="bibr96-11779322231186481"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ur</surname><given-names>A</given-names></name><name name-style="western"><surname>Verma</surname><given-names>K</given-names></name></person-group>. <article-title>Pulmonary edema in COVID-19&#8212;a neural hypothesis</article-title>. <source>ACS Chem Neurosci</source>. <year>2020</year>;<volume>11</volume>:<fpage>2048</fpage>-<lpage>2050</lpage>.<pub-id pub-id-type="pmid">32614178</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acschemneuro.0c00370</pub-id></mixed-citation></ref><ref id="bibr97-11779322231186481"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Kuraishy</surname><given-names>H</given-names></name><name name-style="western"><surname>Al-Gareeb</surname><given-names>A</given-names></name><name name-style="western"><surname>Al-Hussaniy</surname><given-names>H</given-names></name></person-group>, <etal>et al</etal>. <article-title>Neutrophil extracellular traps (NETs) and COVID-19: a new frontier for therapeutic modality</article-title>. <source>Int Immunopharmacol</source>. <year>2022</year>;<volume>104</volume>:<fpage>108516</fpage>.<pub-id pub-id-type="pmid">35032828</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.intimp.2021.108516</pub-id><pub-id pub-id-type="pmcid">PMC8733219</pub-id></mixed-citation></ref><ref id="bibr98-11779322231186481"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name></person-group>. <article-title>MicroRNAs in lung cancer and lung cancer bone metastases: biomarkers for early diagnosis and targets for treatment</article-title>. <source>Recent Pat Anticancer Drug Discov</source>. <year>2015</year>;<volume>10</volume>:<fpage>182</fpage>-<lpage>200</lpage>.<pub-id pub-id-type="pmid">25600282</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1574892810666150120163617</pub-id></mixed-citation></ref><ref id="bibr99-11779322231186481"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name></person-group>, <etal>et al</etal>. <article-title>Novel germline mutation in lung cancer pedigrees establishes BCAR1 as a human cancer susceptibility gene: a case report</article-title>. <source>Ann Transl Med</source>. <year>2022</year>;<volume>10</volume>:<fpage>237</fpage>.<pub-id pub-id-type="pmid">35280415</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/atm-21-7017</pub-id><pub-id pub-id-type="pmcid">PMC8908131</pub-id></mixed-citation></ref><ref id="bibr100-11779322231186481"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>L</given-names></name><name name-style="western"><surname>Jie</surname><given-names>B</given-names></name></person-group>. <article-title>Protumor effects of histone H3-H4 chaperone antisilencing feature 1B gene on lung adenocarcinoma: in silico and in vitro analyses</article-title>. <source>Comput Math Methods Med</source>. <year>2021</year>;<volume>2021</volume>:<fpage>5005459</fpage>.<pub-id pub-id-type="pmid">34956399</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2021/5005459</pub-id><pub-id pub-id-type="pmcid">PMC8702347</pub-id><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retraction-forward" ext-link-type="pmc" xlink:href="PMC10718882"/></mixed-citation></ref><ref id="bibr101-11779322231186481"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suleiman</surname><given-names>A</given-names></name><name name-style="western"><surname>Qaswal</surname><given-names>A</given-names></name><name name-style="western"><surname>Alnouti</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Sedating mechanically ventilated COVID-19 patients with volatile anesthetics: insights on the last-minute potential weapons</article-title>. <source>Sci Pharm</source>. <year>2021</year>;<volume>89</volume>:<fpage>6</fpage>.</mixed-citation></ref><ref id="bibr102-11779322231186481"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Limtung</surname><given-names>P</given-names></name><name name-style="western"><surname>Tung</surname><given-names>H</given-names></name></person-group>. <article-title>Research open</article-title>. <source>J Pharmacol</source>. <year>2020</year>;<volume>3</volume>:<fpage>1</fpage>-<lpage>6</lpage>.</mixed-citation></ref><ref id="bibr103-11779322231186481"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuan</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Babinski</surname><given-names>DE</given-names></name><name name-style="western"><surname>Rabago</surname><given-names>DP</given-names></name><name name-style="western"><surname>Zgierska</surname><given-names>AE</given-names></name></person-group>. <article-title>Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD</article-title>. <source>Brain Res Bull</source>. <year>2022</year>;<volume>187</volume>:<fpage>155</fpage>-<lpage>161</lpage>.<pub-id pub-id-type="pmid">35839903</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.brainresbull.2022.07.005</pub-id><pub-id pub-id-type="pmcid">PMC9279163</pub-id></mixed-citation></ref><ref id="bibr104-11779322231186481"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogundele</surname><given-names>M</given-names></name><name name-style="western"><surname>Ani</surname><given-names>C</given-names></name></person-group>. <article-title>Disparity between different reference values for hypertension among children and adolescents treated for ADHD: experience from a North West England CCH clinic</article-title>. <source>BMJ Paediatr Open</source>. <year>2021</year>;<volume>5</volume>: <fpage>A91</fpage>-<lpage>A92</lpage>.</mixed-citation></ref><ref id="bibr105-11779322231186481"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laboe</surname><given-names>C</given-names></name><name name-style="western"><surname>Batchelder</surname><given-names>E</given-names></name><name name-style="western"><surname>Vasireddy</surname><given-names>D</given-names></name></person-group>. <article-title>Persistent Raynaud&#8217;s phenomenon following methylphenidate hydrochloride use during the COVID-19 pandemic</article-title>. <source>Cureus</source>. <year>2021</year>;<volume>13</volume>:e17647.<pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.17647</pub-id><pub-id pub-id-type="pmcid">PMC8486148</pub-id><pub-id pub-id-type="pmid">34646694</pub-id></mixed-citation></ref><ref id="bibr106-11779322231186481"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nascimento</surname><given-names>JAC</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Santos</surname><given-names>AM</given-names></name><name name-style="western"><surname>Quintans-J&#250;nior</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Walker</surname><given-names>CIB</given-names></name><name name-style="western"><surname>Borges</surname><given-names>LP</given-names></name><name name-style="western"><surname>Serafini</surname><given-names>MR</given-names></name></person-group>. <article-title>SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review</article-title>. <source>Expert Opin Ther Pat</source>. <year>2020</year>;<volume>30</volume>:<fpage>567</fpage>-<lpage>579</lpage>.<pub-id pub-id-type="pmid">32429703</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/13543776.2020.1772231</pub-id></mixed-citation></ref><ref id="bibr107-11779322231186481"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>W</given-names></name><name name-style="western"><surname>Penaherrera</surname><given-names>E</given-names></name><name name-style="western"><surname>Desir</surname><given-names>D</given-names></name></person-group>, <etal>et al</etal>. <article-title>Bi-directional acceleration of alcohol use and opioid use disorder</article-title>. <source>J Drug Alcohol Res</source>. <year>2019</year>;<volume>2019</volume>:<fpage>236084</fpage>.<pub-id pub-id-type="pmid">32440365</pub-id><pub-id pub-id-type="pmcid">PMC7241514</pub-id></mixed-citation></ref><ref id="bibr108-11779322231186481"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrett</surname><given-names>E</given-names></name><name name-style="western"><surname>Apodaca</surname><given-names>K</given-names></name></person-group>. <article-title>Response to &#8220;alcohol and COVID-19: how do we respond to this growing public health crisis?.&#8221;</article-title><source>J Gen Intern Med</source>. <year>2021</year>;<volume>36</volume>:<fpage>2476</fpage>-<lpage>2476</lpage>.<pub-id pub-id-type="pmid">33904051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11606-021-06824-3</pub-id><pub-id pub-id-type="pmcid">PMC8075275</pub-id></mixed-citation></ref><ref id="bibr109-11779322231186481"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hasan</surname><given-names>MI</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>MH</given-names></name><name name-style="western"><surname>Islam</surname><given-names>MB</given-names></name><name name-style="western"><surname>Islam</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Hossain</surname><given-names>MA</given-names></name><name name-style="western"><surname>Moni</surname><given-names>MA</given-names></name></person-group>. <article-title>Systems biology and bioinformatics approach to identify blood based signatures molecules and drug targets of patient with COVID-19</article-title>. <source>Inform Med Unlocked</source>. <year>2022</year>;<volume>28</volume>:<fpage>100840</fpage>.<pub-id pub-id-type="pmid">34981034</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.imu.2021.100840</pub-id><pub-id pub-id-type="pmcid">PMC8716147</pub-id></mixed-citation></ref><ref id="bibr110-11779322231186481"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DiNicolantonio</surname><given-names>JJ</given-names></name><name name-style="western"><surname>McCarty</surname><given-names>M</given-names></name></person-group>. <article-title>Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase</article-title>. <source>Open Heart</source>. <year>2020</year>;<volume>7</volume>:e001337.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/openhrt-2020-001337</pub-id><pub-id pub-id-type="pmcid">PMC7298678</pub-id><pub-id pub-id-type="pmid">32532805</pub-id></mixed-citation></ref><ref id="bibr111-11779322231186481"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plasencia-Garc&#237;a</surname><given-names>BO</given-names></name><name name-style="western"><surname>Rico-Rangel</surname><given-names>MI</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Men&#233;ndez</surname><given-names>G</given-names></name><name name-style="western"><surname>Rubio-Garc&#237;a</surname><given-names>A</given-names></name><name name-style="western"><surname>Torell&#243;-Iserte</surname><given-names>J</given-names></name><name name-style="western"><surname>Crespo-Facorro</surname><given-names>B</given-names></name></person-group>. <article-title>Drug-drug interactions between COVID-19 treatments and antidepressants, mood stabilizers/anticonvulsants, and benzodiazepines: integrated evidence from 3 databases</article-title>. <source>Pharmacopsychiatry</source>. <year>2022</year>;<volume>55</volume>:<fpage>40</fpage>-<lpage>47</lpage>.<pub-id pub-id-type="pmid">34171927</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/a-1492-3293</pub-id></mixed-citation></ref><ref id="bibr112-11779322231186481"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>M</given-names></name><name name-style="western"><surname>Islam</surname><given-names>T</given-names></name><name name-style="western"><surname>Shahjaman</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis</article-title>. <source>Brief Bioinform</source>. <year>2021</year>;<volume>22</volume>:bbab262.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bib/bbab262</pub-id><pub-id pub-id-type="pmcid">PMC8344483</pub-id><pub-id pub-id-type="pmid">34260684</pub-id></mixed-citation></ref><ref id="bibr113-11779322231186481"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marks</surname><given-names>DM</given-names></name><name name-style="western"><surname>Bolognesi</surname><given-names>MP</given-names></name></person-group>. <article-title>Open-label milnacipran for patients with persistent knee pain 1 year or longer after total knee arthroplasty: a pilot study</article-title>. <source>Prim Care Companion CNS Disord</source>. <year>2013</year>;<volume>15</volume>:22m03432.<pub-id pub-id-type="doi" assigning-authority="pmc">10.4088/PCC.12m01496</pub-id><pub-id pub-id-type="pmcid">PMC3869602</pub-id><pub-id pub-id-type="pmid">24392250</pub-id></mixed-citation></ref><ref id="bibr114-11779322231186481"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name></person-group>. <article-title>Real-world pharmacological treatment of patients with postpartum depression in China from2016 to 2020: a cross-sectional analysis</article-title>. <source>Saudi Pharm J</source>. <year>2022</year>;<volume>30</volume>:<fpage>1418</fpage>-<lpage>1425</lpage>.<pub-id pub-id-type="pmid">36387336</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jsps.2022.07.002</pub-id><pub-id pub-id-type="pmcid">PMC9649344</pub-id></mixed-citation></ref><ref id="bibr115-11779322231186481"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Firestone</surname><given-names>K</given-names></name><name name-style="western"><surname>Holton</surname><given-names>K</given-names></name><name name-style="western"><surname>Mist</surname><given-names>S</given-names></name><name name-style="western"><surname>Wright</surname><given-names>C</given-names></name><name name-style="western"><surname>Jones</surname><given-names>K</given-names></name></person-group>. <article-title>Optimizing fibromyalgia management</article-title>. <source>Nurse Pract</source>. <year>2012</year>;<volume>37</volume>:<fpage>12</fpage>-<lpage>21</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.NPR.0000412891.19933.48</pub-id><pub-id pub-id-type="pmid">22395744</pub-id></mixed-citation></ref><ref id="bibr116-11779322231186481"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bilbul</surname><given-names>M</given-names></name><name name-style="western"><surname>Paparone</surname><given-names>P</given-names></name><name name-style="western"><surname>Kim</surname><given-names>A</given-names></name><name name-style="western"><surname>Mutalik</surname><given-names>S</given-names></name><name name-style="western"><surname>Ernst</surname><given-names>C</given-names></name></person-group>. <article-title>Psychopharmacology of COVID-19</article-title>. <source>Psychosomatics</source>. <year>2020</year>;<volume>61</volume>:<fpage>411</fpage>-<lpage>427</lpage>.<pub-id pub-id-type="pmid">32425246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.psym.2020.05.006</pub-id><pub-id pub-id-type="pmcid">PMC7232075</pub-id></mixed-citation></ref><ref id="bibr117-11779322231186481"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomo</surname><given-names>S</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>M</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>P</given-names></name><name name-style="western"><surname>Garg</surname><given-names>M</given-names></name></person-group>. <article-title>Does dehydroepiandrosterone sulfate have a role in COVID-19 prognosis and treatment?</article-title><source>Endocr Regul</source>. <year>2021</year>;<volume>55</volume>:<fpage>174</fpage>-<lpage>181</lpage>.<pub-id pub-id-type="pmid">34523302</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2478/enr-2021-0019</pub-id></mixed-citation></ref><ref id="bibr118-11779322231186481"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al- Ruweidi</surname><given-names>M</given-names></name><name name-style="western"><surname>Ali</surname><given-names>F</given-names></name><name name-style="western"><surname>Shurbaji</surname><given-names>S</given-names></name><name name-style="western"><surname>Popelka</surname><given-names>A</given-names></name><name name-style="western"><surname>Yalcin</surname><given-names>H</given-names></name></person-group>. <article-title>Dexamethasone and transdehydroandrosterone significantly reduce pulmonary epithelial cell injuries associated with mechanical ventilation</article-title>. <source>J Appl Physiol</source>. <year>2021</year>;<volume>130</volume>:<fpage>1143</fpage>-<lpage>1151</lpage>.<pub-id pub-id-type="pmid">33600286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/japplphysiol.00574.2020</pub-id><pub-id pub-id-type="pmcid">PMC8384562</pub-id></mixed-citation></ref><ref id="bibr119-11779322231186481"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Each</surname><given-names>D</given-names></name><name name-style="western"><surname>Brooke</surname><given-names>G</given-names></name><name name-style="western"><surname>Bevan</surname><given-names>C</given-names></name></person-group>. <article-title>Roles of steroid receptors in the lung and COVID-19</article-title>. <source>Essays Biochem</source>. <year>2021</year>;<volume>65</volume>:<fpage>1025</fpage>-<lpage>1038</lpage>.<pub-id pub-id-type="pmid">34328182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/EBC20210005</pub-id><pub-id pub-id-type="pmcid">PMC8628186</pub-id></mixed-citation></ref><ref id="bibr120-11779322231186481"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cruz</surname><given-names>AT</given-names></name><name name-style="western"><surname>Zeichner</surname><given-names>SL</given-names></name></person-group>. <article-title>COVID-19 in children: initial characterization of the pediatric disease</article-title>. <source>Pediatrics</source>. <year>2020</year>;<volume>145</volume>:e20200834.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2020-0834</pub-id><pub-id pub-id-type="pmid">32179659</pub-id></mixed-citation></ref><ref id="bibr121-11779322231186481"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hashimoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Hashimoto</surname><given-names>K</given-names></name></person-group>. <article-title>Mechanisms of action of fluvoxamine for COVID-19: a historical review</article-title>. <source>Mol Psychiatry</source>. <year>2022</year>;<volume>27</volume>:<fpage>1898</fpage>-<lpage>1907</lpage>.<pub-id pub-id-type="pmid">34997196</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41380-021-01432-3</pub-id><pub-id pub-id-type="pmcid">PMC8739627</pub-id></mixed-citation></ref><ref id="bibr122-11779322231186481"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pawlikowski</surname><given-names>M</given-names></name><name name-style="western"><surname>Winczyk</surname><given-names>K</given-names></name></person-group>. <article-title>Endocrine and metabolic aspects of COVID-19</article-title>. <source>Endokrynol Pol</source>. <year>2021</year>;<volume>72</volume>:<fpage>256</fpage>-<lpage>260</lpage>.<pub-id pub-id-type="pmid">34010445</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5603/EP.a2021.0023</pub-id></mixed-citation></ref><ref id="bibr123-11779322231186481"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spick</surname><given-names>M</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>HM</given-names></name><name name-style="western"><surname>Frampas</surname><given-names>CF</given-names></name></person-group>, <etal>et al</etal>. <article-title>An integrated analysis and comparison of serum, saliva and sebum for COVID-19 metabolomics</article-title>. <source>Sci Rep</source>. <year>2022</year>;<volume>12</volume>:<fpage>11867</fpage>.<pub-id pub-id-type="pmid">35831456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-022-16123-4</pub-id><pub-id pub-id-type="pmcid">PMC9278322</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>